The DOI matches its Crossref record, with a small difference in title or year; 344 of the 347 references it cites were found in a registry or an index, and 2 are not checked yet; 102 of the 369 sources its claims cite were checked for support.
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association
Abstract
BACKGROUND: Infective endocarditis is a potentially lethal disease that has undergone major changes in both host and pathogen. The epidemiology of infective endocarditis has become more complex with today's myriad healthcare-associated factors that predispose to infection. Moreover, changes in pathogen prevalence, in particular a more common staphylococcal origin, have affected outcomes, which have not improved despite medical and surgical advances. METHODS AND RESULTS: This statement updates the 2005 iteration, both of which were developed by the American Heart Association under the auspices of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease of the Young. It includes an evidence-based system for diagnostic and treatment recommendations used by the American College of Cardiology and the American Heart Association for treatment recommendations. CONCLUSIONS: Infective endocarditis is a complex disease, and patients with this disease generally require management by a team of physicians and allied health providers with a variety of areas of expertise. The recommendations provided in this document are intended to assist in the management of this uncommon but potentially deadly infection. The clinical variability and complexity in infective endocarditis, however, dictate that these recommendations be used to support and not supplant decisions in individual patient management.
Verified 2026-10-11 · 2 references not checked yet
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
163 No full text of the sources · 36 Partly supported · 33 No basis given · 32 Supported · 27 Own interpretation · 13 Sources not found · 10 Not checked yet · 8 Supported so far · 6 Couldn’t confirm · 2 Mixed support · 2 Not supported · 2 Own result · accuracy not yet measured
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“a retrospective study of 410 patients showed good agreement (72%-90%) between the Duke criteria and clinical assessment by infectious disease experts blinded to underlying IE risk factors.39”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Diagnosis
What the sources say
- Disputedcites [39] 39. Fowler VG Jr, Sanders LL, Kong LK, McClelland RS, Gottlieb GS, Li J, Ryan T, Sexton DJ, Roussakis G, Harrell LJ, Corey GR. Infective endocar- ditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis. 1999;28:106-114. doi: 10.1086/515076. sourceExperimental — accuracy not yet measured
The Abstract describes a prospective study of 59 patients with definite infective endocarditis, not a retrospective study of 410 patients. The Definition of IE says the authors used the Duke criteria, but our copy does not report the claimed 72%–90% agreement with blinded infectious disease experts. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plaincorrelationaln = 410- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In contrast, as confirmed above by Vilacosta et al, 278 staphylococcal or fungal IE appears to carry a high incidence rate of embolization independently of vegetation size.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Disputedcites [278] sourceExperimental — accuracy not yet measured
The Discussion says earlier reports suggested increased embolization risk with Staphylococcus and fungi, but this study found no significant difference by microorganism. It also reports that, in staphylococcal endocarditis, large vegetations had a higher incidence of embolism. The Clinical and microbiologic data section identifies vegetation size—not microorganism—as the only independent predictor in its multivariate analysis. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Every source the paper cites for this claim was checked and supports it.
In the paper
“adjustment of the Duke criteria to require a minimum of 1 major plus 1 minor criterion or 3 minor criteria as a”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Supportedcites [24] 24. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diag- nosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638. doi: 10.1086/313753. source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“daptomycin has been evaluated in the treatment of S aureus bacteremia and IE in a randomized, controlled trial.13”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Abstract
What the sources say
- Supportedcites [13] 13. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-665. doi: 10.1056/NEJMoa053783. source
The Study Design section identifies this as an open-label, randomized trial, and Randomization, Treatment, and Monitoring describes assignment to daptomycin or standard therapy. The Discussion states that the trial evaluated treatment of S. aureus bacteremia and endocarditis. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“the proportion of IE patients undergoing surgery has increased over time to reach ≈50%.1,10,11”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Abstract
What the sources say
- Supportedcites [1] 1. Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, Doco- Lecompte T, Celard M, Poyart C, Strady C, Chirouze C, Bes M, Cambau E, Iung B, Selton-Suty C, Hoen B; AEPEI Study Group. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifi- cations: three successive population-based surveys. J Am Coll Cardiol. 2012;59:1968-1976. doi: 10.1016/j.jacc.2012.02.029. source
The Outcome section reports that cardiac surgery during the acute phase of infective endocarditis increased from 31% in 1991 to 50% in 1999, then remained at 50%. This supports the cited claim's approximate figure and temporal trend. (LLM, conf=0.95)
- Partly supportedcites [10] 10. Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG Jr, Corey GR, Chu VH, Fenely M, Pachirat O, Tan RS, Watkin R, Ionac A, Moreno A, Mestres CA, Casabé J, Chipigina N, Eisen DP, Spelman D, Delahaye F, Peterson G, Olaison L, Wang A; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121:1005-1013. doi: 10.1161/CIRCULATIONAHA.109.86 sourceExperimental — accuracy not yet measured
The Results report that 720 of 1,552 eligible patients with native valve endocarditis (46%) underwent early surgery, supporting the approximate 50% figure for that study group. The paper does not establish that the proportion increased over time or that the figure applies to all infective endocarditis patients. (LLM, conf=0.88)
- Partly supportedcites [11] 11. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306:2239-2247. doi: 10.1001/jama.2011.1701. sourceExperimental — accuracy not yet measured
The Results report that another study found surgery in 46% of patients with left-sided infective endocarditis and heart failure, a restricted group close to the claimed 50%. This paper reports surgery in 62% of its own patients with heart failure. Neither passage establishes that surgery rates increased over time or reached approximately 50% among infective endocarditis patients generally. (LLM, conf=0.77)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Therefore, this minor criterion was eliminated in the modified Duke criteria.24”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Supportedcites [24] 24. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diag- nosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638. doi: 10.1086/313753. source
In “Proposed Clarifications and Modifications of Minor Criteria for the Diagnosis of IE” (page unavailable), the authors identify the echocardiographic minor criterion and say it should be eliminated. The paper’s modified-criteria listing explicitly states that echocardiographic minor criteria were eliminated. (LLM, conf=0.95)
plainn = 800- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Thus, an anti-phase I immunoglobulin G antibody titer ≥1:800 or a single blood culture positive for C burnetii should be a major criterion in the modified Duke schema.24”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Supportedcites [24] 24. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diag- nosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638. doi: 10.1086/313753. source
In “Redefining the Major Criteria for the Diagnosis of IE,” the authors explicitly recommend making an anti-phase I IgG titer of at least 1:800 or a single blood culture positive for C. burnetii a major Duke criterion. The passage gives the threshold and alternatives stated in the claim. (LLM, conf=0.95)
plainn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“the modified Duke criteria (Tables 2 and 3) recommend the inclusion of S aureus bacteremia as a major criterion, regardless of whether the infection is hospital acquired (with or without a removable source of infection) or community acquired.24”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Supportedcites [24] 24. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diag- nosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638. doi: 10.1086/313753. source
The Abstract and “Redefining the Major Criteria for the Diagnosis of IE” explicitly propose S. aureus bacteremia as a major criterion regardless of nosocomial acquisition or a removable source of infection. This covers the citing sentence’s hospital- versus community-acquired distinction. No page numbers are supplied in our copy. (LLM, conf=0.95)
plainn = 59- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“For example, the curative dose of penicillin for streptococcal infections in animal models has been shown to increase markedly with the number of organisms inoculated and the duration of the infection, presumably because of the interim increase in the number of organisms in the infected host.76”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Inoculum Effect
What the sources say
- Supportedcites [76] 76. Eagle H. The effect of the size of the inoculum and the age of the infection on the curative dose of penicillin in experimental infections with streptococci, pneumococci, and Treponema pallidum. J Exp Med. 1949;90:595-607. source
The Discussion (p. 606) states that the curative dose increased with both inoculum size and infection age in experimental infections in mice and rabbits, and identifies the larger bacterial population as the primary explanation. It specifically reports a rapid increase in the curative dose for the streptococcal infections studied. (LLM, conf=0.94)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Combination therapy with penicillin or ceftriaxone and an aminoglycoside for 2 weeks is highly effective in viridans group streptococci (VGS) IE 90 in very select patients with uncomplicated infection.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Duration of Antimicrobial Therapy
What the sources say
- Supportedcites [90] 90. Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocar- ditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis. 1995;21:1406-1410. source
The Introduction describes two weeks of penicillin plus an aminoglycoside as effective for streptococcal endocarditis. The study summary reports high cure rates with 14 days of ceftriaxone plus netilmicin; 31 of its 52 patients had viridans streptococcal infection. Patients and Methods limits enrollment to ceftriaxone-susceptible native-valve infection and lists exclusions. Page numbers were not available in our copy. (LLM, conf=0.88)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Of interest, right-sided vegetations tend to have lower bacterial densities, which may result from host defense mechanisms, including polymorphonuclear activity or plateletderived antibacterial cationic peptides.90,91,93”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Duration of Antimicrobial Therapy
What the sources say
- Could not verifycites [90] 90. Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocar- ditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis. 1995;21:1406-1410. sourceExperimental — accuracy not yet measured
The Results describe the infected valves and organisms in this treatment study, but do not compare bacterial densities in right- and left-sided vegetations. The Discussion addresses antibiotic efficacy, not polymorphonuclear activity or platelet-derived antibacterial peptides; searches for those mechanisms found no supporting passage. Page numbers were unavailable in our copy. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [91] 91. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med. 1988;109:619-624. source
- Partly supportedcites [93] 93. Bayer AS, Cheng D, Yeaman MR, Corey GR, McClelland RS, Harrel LJ, Fowler VG Jr. In vitro resistance to thrombin-induced platelet microbici- dal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. Antimicrob Agents Chemother. 1998;42:3169-3172. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) describes platelet-released antimicrobial peptides as a host defense at endovascular sites and links resistance to those peptides with proliferation in cardiac vegetations. It does not report that right-sided vegetations have lower bacterial densities or address polymorphonuclear activity, so it supports only the platelet-peptide mechanism in the cited sentence. (LLM, conf=0.87)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The effect of high bacterial densities on antimicrobial activity is called the inoculum effect in which certain groups of antimicrobials commonly used to treat IE such as β-lactams and glycopeptides (and, to a lesser extent, lipopeptides such as daptomycin) are less active against highly dense bacterial populations.[73][74][75]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Inoculum Effect
What the sources say
- Supportedcites [73] 73. LaPlante KL, Rybak MJ. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacody- namic model. Antimicrob Agents Chemother. 2004;48:4665-4672. doi: 10.1128/AAC.48.12.4665-4672.2004. source
The Discussion describes an inoculum effect for β-lactams and glycopeptides at high bacterial densities. Its conclusion ranks the effect on nafcillin above vancomycin above daptomycin; the paper reports that daptomycin was affected only minimally in its in vitro model. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [74] 74. Arhin FF, Sarmiento I, Parr TR Jr, Moeck G. Activity of oritavancin and comparators in vitro against standard and high inocula of Staphylococcus aureus. Int J Antimicrob Agents. 2012;39:159-162. doi: 10.1016/j. ijantimicag.2011.09.017. source
- Not checked — no full text of the sourcecites [75] 75. Rose WE, Leonard SN, Rossi KL, Kaatz GW, Rybak MJ. Impact of inoc- ulum size and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) on vancomycin activity and emergence of VISA in an in vitro pharmacodynamic model. Antimicrob Agents Chemother. 2009;53:805-807. doi: 10.1128/AAC.01009-08. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In addition, the stationary growth-phase conditions make it less likely that bacterial cell wall-active antibiotics (β-lactams and glycopeptides) are optimally effective.[77][78][79]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Inoculum Effect
What the sources say
- Partly supportedcites [77] 77. Lunde CS, Rexer CH, Hartouni SR, Axt S, Benton BM. Fluorescence microscopy demonstrates enhanced targeting of telavancin to the divi- sion septum of Staphylococcus aureus. Antimicrob Agents Chemother. 2010;54:2198-2200. doi: 10.1128/AAC.01609-09. sourceExperimental — accuracy not yet measured
The passage labeled Abstract (page unavailable) says glycopeptides must reach the site of active cell-wall biosynthesis to act on their targets. It does not address stationary-phase conditions, reduced antibiotic effectiveness during that phase, or β-lactams. (LLM, conf=0.78)
- Could not verifycites [78] 78. Pogliano J, Pogliano N, Silverman JA. Daptomycin-mediated reorga- nization of membrane architecture causes mislocalization of essential cell division proteins. J Bacteriol. 2012;194:4494-4504. doi: 10.1128/ JB.00011-12. sourceExperimental — accuracy not yet measured
The Introduction identifies vancomycin and oxacillin as cell wall-active antibiotics, but does not discuss their effectiveness during stationary-phase growth. A References entry mentions stationary-phase cells only in the title of a study about daptomycin. Searches for stationary-phase efficacy of β-lactams and glycopeptides found no passage addressing the claim. (LLM, conf=0.75)
- Not checked — no full text of the sourcecites [79] 79. Eng RH, Padberg FT, Smith SM, Tan EN, Cherubin CE. Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother. 1991;35:1824-1828. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“An inoculum effect has been demonstrated with penicillin versus streptococci in both in vitro and animal models.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Inoculum Effect
What the sources say
- Partly supportedcites [76] 76. Eagle H. The effect of the size of the inoculum and the age of the infection on the curative dose of penicillin in experimental infections with streptococci, pneumococci, and Treponema pallidum. J Exp Med. 1949;90:595-607. sourceExperimental — accuracy not yet measured
The Introduction (p. 595) describes an in vitro inoculum effect for penicillin against bacteria, but does not identify those bacteria as streptococci. It says the relationship is confirmed in streptococcal infections of mice and rabbits, and the Experimental results (p. 599) report higher curative doses with larger streptococcal inocula. Thus the animal-model part is supported, but the streptococcus-specific in vitro part is not established by our copy. (LLM, conf=0.86)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“early investigations 64,65 of 3D TEE have demonstrated advantages over 2-dimensional TEE (which is routinely used) to better detect and delineate vegetations and to identify IE complications and their relationships with surrounding structures.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > 3D Echocardiography and Other Imaging Modalities
What the sources say
- Not checked — no full text of the sourcecites [64] 64. Hansalia S, Biswas M, Dutta R, Hage FG, Hsiung MC, Nanda NC, Singh P, Manda J, Kesanolla SK, Wei J, Yin WH. The value of live/real time three-dimensional transesophageal echocardiography in the assessment of valvular vegetations. Echocardiography. 2009;26:1264-1273. doi: 10.1111/j.1540-8175.2009.01042.x. source
- Partly supportedcites [65] 65. Liu YW, Tsai WC, Lin CC, Hsu CH, Li WT, Lin LJ, Chen JH. Usefulness of real-time three-dimensional echocardiography for diagnosis of infective endocarditis. Scand Cardiovasc J. 2009;43:318-323. doi: 10.1080/14017430902737940. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Even TEE may miss initial perivalvular abscesses, particularly when the study is performed early in the patient's illness.54”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Echocardiography
What the sources say
- Partly supportedcites [54] 54. Daniel WG, Mügge A, Martin RP, Lindert O, Hausmann D, Nonnast- Daniel B, Laas J, Lichtlen PR. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med. 1991;324:795-800. doi: 10.1056/NEJM199103213241203. sourceExperimental — accuracy not yet measured
The Transesophageal Echocardiography section (p. 2) reports that TEE detected 40 of 46 abscesses, supporting that it can miss some. The Limitations of the Study (p. 5) describes a small abscess that can be missed because of acoustic shadowing, but neither passage links missed abscesses to studies performed early in the patient's illness. (LLM, conf=0.88)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Of interest, right-sided vegetations tend to have lower bacterial densities, which may result from host defense mechanisms, including polymorphonuclear activity or plateletderived antibacterial cationic peptides.90,91,93”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Duration of Antimicrobial Therapy
What the sources say
- Could not verifycites [90] 90. Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocar- ditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis. 1995;21:1406-1410. sourceExperimental — accuracy not yet measured
The Results describe valve involvement and vegetations, but do not compare bacterial densities in right- and left-sided vegetations. Searches for that comparison and for the proposed host-defense mechanisms found no passage addressing either point in our copy. (LLM, conf=0.77)
- Not checked — no full text of the sourcecites [91] 91. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med. 1988;109:619-624. source
- Could not verifycites [93] 93. Bayer AS, Cheng D, Yeaman MR, Corey GR, McClelland RS, Harrel LJ, Fowler VG Jr. In vitro resistance to thrombin-induced platelet microbici- dal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. Antimicrob Agents Chemother. 1998;42:3169-3172. sourceExperimental — accuracy not yet measured
The Discussion describes platelet antimicrobial peptides as a host defense and discusses bacterial proliferation within cardiac vegetations. It does not compare bacterial densities in right-sided and left-sided vegetations; searches for that comparison found no passage in our copy. (LLM, conf=0.76)
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“Of interest, data suggest that the overall outcomes for patients with CoNS IE and S aureus IE are similar.137”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Coagulase-Negative Staphylococci
What the sources say
- Supportedcites [137] 137. Chu VH, Woods CW, Miro JM, Hoen B, Cabell CH, Pappas PA, Federspiel J, Athan E, Stryjewski ME, Nacinovich F, Marco F, Levine DP, Elliott TS, Fortes CQ, Tornos P, Gordon DL, Utili R, Delahaye F, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis- Prospective Cohort Study Group. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis. 2008;46:232-242. doi: 10.1086/524666. source
The Abstract reports similar mortality for native valve endocarditis caused by CoNS and S. aureus (25% versus 27%). The discussion also says CoNS endocarditis was not associated with better outcomes despite more frequent surgery, supporting the citing sentence’s hedged summary. (LLM, conf=0.88)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This increase is primarily a consequence of healthcare contact (eg, intravascular catheters, surgical wounds, indwelling prosthetic devices, hemodialysis) 6,8,9”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > S aureus
What the sources say
- Not checked — no full text of the sourcecites [6] 6. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS; ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress [published correction appears in JAMA. 2005;294:900]. JAMA. 2005;293:3012-3021. doi: 10.1001/jama.293.24.3012. source
- Partly supportedcites [8] 8. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infec- tive endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463- 473. doi: 10.1001/archinternmed.2008.603. sourceExperimental — accuracy not yet measured
The ‘Changes in Microbiologic Characteristics of IE’ section attributes the shift toward S aureus IE in part to health care contact and invasive procedures, but also names intravenous drug use. It does not say health care contact is the primary cause of the increase. The Definitions section includes wound care and hemodialysis as forms of health care contact; it does not establish the full list of examples as causes of the increase. Page numbers were not available in our copy. (LLM, conf=0.87)
- Partly supportedcites [9] 9. Benito N, Miró JM, de Lazzari E, Cabell CH, del Río A, Altclas J, Commerford P, Delahaye F, Dragulescu S, Giamarellou H, Habib G, Kamarulzaman A, Kumar AS, Nacinovich FM, Suter F, Tribouilloy C, Venugopal K, Moreno A, Fowler VG Jr; ICE-PCS (International Collaboration on Endocarditis Prospective Cohort Study) Investigators. Health care-associated native valve endocarditis: importance of non- nosocomial acquisition [published correction appears in Ann Intern Med. 2010;152:480]. Ann Intern Med. 2009;150:586-594. doi: 10.7326/0003-4819-150-9-200905050-00004 sourceExperimental — accuracy not yet measured
The Discussion identifies health care contact as an important risk factor for native valve endocarditis, and the Results identify S. aureus as its most common cause in health care–associated cases. The Results also report intravascular catheters as a presumed infection source and an association with hemodialysis. The paper does not establish that health care contact is the primary cause of an increase in S. aureus endocarditis, or identify surgical wounds and indwelling prosthetic devices as causes of that increase. No page numbers were available in our copy. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Increasing rates of oxacillin-resistant S aureus or MRSA isolates in both hospital and community settings and the recovery of clinical S aureus isolates both partially and fully 138,139 resistant to vancomycin have complicated the treatment of S aureus IE.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > S aureus
What the sources say
- Not checked — no full text of the sourcecites [138] 138. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK; Vancomycin-Resistant Staphylococcus aureus Investigative Team. Infection with vancomycin-resistant Staphylococcus aureus contain- ing the vanA resistance gene. N Engl J Med. 2003;348:1342-1347. doi: 10.1056/NEJMoa025025. source
- Partly supportedcites [139] 139. Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC; Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group. Epidemiological and microbiological char- acterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis. 2003;36:429-439. doi: 10.1086/346207. sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) describes S. aureus as a cause of community-acquired and health care-associated infections, and the Clinical description study (page unavailable) lists MRSA endocarditis cases. The copy does not establish increasing MRSA rates in either setting or show that those rates complicated treatment of infective endocarditis. (LLM, conf=0.76)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“and is especially prevalent in North America.6,138,139”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > S aureus
What the sources say
- Not checked — no full text of the sourcecites [6] 6. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS; ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress [published correction appears in JAMA. 2005;294:900]. JAMA. 2005;293:3012-3021. doi: 10.1001/jama.293.24.3012. source
- Not checked — no full text of the sourcecites [138] 138. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK; Vancomycin-Resistant Staphylococcus aureus Investigative Team. Infection with vancomycin-resistant Staphylococcus aureus contain- ing the vanA resistance gene. N Engl J Med. 2003;348:1342-1347. doi: 10.1056/NEJMoa025025. source
- Could not verifycites [139] 139. Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC; Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group. Epidemiological and microbiological char- acterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis. 2003;36:429-439. doi: 10.1086/346207. sourceExperimental — accuracy not yet measured
The Clinical description study section reports one US patient whose S. aureus bloodstream infection was complicated by endocarditis. The Discussion addresses the rarity of reduced vancomycin susceptibility, not trends in infective endocarditis. Searches for endocarditis incidence and North American prevalence found no passage establishing that S. aureus infective endocarditis is increasing or especially prevalent in North America; page numbers were unavailable in our copy. (LLM, conf=0.74)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“the recovery of clinical S aureus isolates both partially and fully 138,139 resistant to vancomycin have complicated the treatment of S aureus IE.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > S aureus
What the sources say
- Not checked — no full text of the sourcecites [138] 138. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK; Vancomycin-Resistant Staphylococcus aureus Investigative Team. Infection with vancomycin-resistant Staphylococcus aureus contain- ing the vanA resistance gene. N Engl J Med. 2003;348:1342-1347. doi: 10.1056/NEJMoa025025. source
- Partly supportedcites [139] 139. Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC; Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group. Epidemiological and microbiological char- acterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis. 2003;36:429-439. doi: 10.1086/346207. sourceExperimental — accuracy not yet measured
The Clinical description study reports a vancomycin-intermediate S. aureus (VISA) infection complicated by endocarditis, and Table 1 describes a patient with mitral valve endocarditis who died. The paper also mentions a fully vancomycin-resistant isolate, but not in an endocarditis case; it does not establish that both forms of resistance complicated treatment of S. aureus infective endocarditis. Page numbers were not available in our copy. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In a registrational open-label, multinational, clinical trial for the treatment of S aureus bacteremia or right-sided IE comparing the efficacy of daptomycin monotherapy with therapy that included low-dose (1 mg/kg IV every 8 hours or adjusted on the basis of renal function) gentamicin for the first 4 days, patients did equally well in either treatment arm.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Right-Sided IE in IDUs
What the sources say
- Supportedcites [13] 13. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-665. doi: 10.1056/NEJMoa053783. source
The Study Design and Patients sections describe an open-label trial conducted at 44 sites in four countries. Randomization, Treatment, and Monitoring specifies gentamicin for the first four days in the standard-therapy arm. The Outcome section reports similar clinical success rates—44.2% with daptomycin and 41.7% with standard therapy—and concludes that daptomycin was not inferior. Page numbers were not available in our copy. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As noted above, in addition to their importance in PVE, CoNS now cause a significant but relatively small proportion of NVE cases. 2”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Coagulase-Negative Staphylococci
What the sources say
- Partly supportedcites [2] 2. Correa de Sa DD, Tleyjeh IM, Anavekar NS, Schultz JC, Thomas JM, Lahr BD, Bachuwar A, Pazdernik M, Steckelberg JM, Wilson WR, Baddour LM. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota [published correction appears in Mayo Clin Proc. 2010;85:772]. Mayo Clin Proc. 2010;85:422-426. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a high incidence of coagulase-negative staphylococcal endocarditis among recent cases and says native-valve cases due to these organisms deserve monitoring. It does not give the proportion of native-valve cases they cause, so the characterization of that proportion as relatively small is not established by our copy. (LLM, conf=0.78)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The combination of daptomycin and a β-lactam antibiotic has been reported to be effective in treating a limited number of patients with persistent MRSA bacteremia.168”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Additional or Adjunctive Therapies
What the sources say
- Supportedcites [168] source
The Methods section identifies seven patients whose persistent MRSA bacteremia was eradicated with daptomycin plus an antistaphylococcal β-lactam. The Discussion reports rapid bacteremia clearance in all seven, supporting the claim that the combination was reported effective in a limited number of patients. (LLM, conf=0.94)
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In the above-noted multinational trial 13 of S aureus bacteremia and right-sided IE, this agent (at 6 mg•kg -1 •d -1 ) was noninferior to standard therapy with vancomycin or an antistaphylococcal penicillin plus low-dose, short-course gentamicin.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Therapy of MSSA IE in Patients Allergic to or Intolerant of β-Lactams
What the sources say
- Supportedcites [13] 13. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-665. doi: 10.1056/NEJMoa053783. source
The Patients section reports treatment at 44 sites in four countries, supporting the description of a multinational trial. Randomization, Treatment, and Monitoring specifies daptomycin at 6 mg/kg daily versus vancomycin or an antistaphylococcal penicillin, with gentamicin planned for the first four days in the standard-therapy group. The Discussion concludes that daptomycin was not inferior for S. aureus bacteremia and right-sided endocarditis. (LLM, conf=0.95)
plainn = 18- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In an in vitro study, 167 the addition of trimethoprim-sulfamethoxazole to daptomycin was rapidly bactericidal for a daptomycin-nonsusceptible strain compared with daptomycin monotherapy.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Additional or Adjunctive Therapies
What the sources say
- Supportedcites [167] 167. Steed ME, Vidaillac C, Rybak MJ. Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations. Antimicrob Agents Chemother. 2010;54:5187-5192. doi: 10.1128/ AAC.00536-10. 168 source
The Abstract reports that daptomycin plus trimethoprim-sulfamethoxazole was bactericidal against the daptomycin-nonsusceptible strain SA-684 at 4 hours, whereas daptomycin alone reached bactericidal activity at 24 hours. The Discussion also describes the combination as rapidly bactericidal and superior to daptomycin alone in the in vitro model. (LLM, conf=0.94)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Importantly, the small number (n=18; 9 in each arm) of patients with left-sided IE enrolled in the trial prevented meaningful conclusions on the comparative efficacy of daptomycin in this infection.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Therapy of MSSA IE in Patients Allergic to or Intolerant of β-Lactams
What the sources say
- Supportedcites [13] 13. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-665. doi: 10.1056/NEJMoa053783. source
The Outcome section reports nine patients with left-sided endocarditis in each treatment group (18 total). The Discussion identifies the small number of these patients as a limitation and confines its noninferiority conclusion to bacteremia and right-sided endocarditis, supporting the claim that the trial could not establish comparative efficacy for left-sided disease. (LLM, conf=0.93)
plaindirectn = 18- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“As noted above, 149 the risk of clinically significant nephrotoxicity with even short courses of adjunctive low-dose gentamicin for S aureus bacteremia and right-sided IE can be substantial.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > IE in Non-IDUs
What the sources say
- Supportedcites [149] 149. Cosgrove SE, Vigliani GA, Fowler VG Jr, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW. Initial low- dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis. 2009;48:713-721. doi: 10.1086/597031. source
The Discussion reports that even a few days of initial low-dose gentamicin alongside standard therapy for S. aureus bacteremia or native-valve endocarditis was frequently associated with renal dysfunction. It describes clinically relevant declines in renal function after a median exposure of four days and notes that renal dysfunction was frequent despite many patients having uncomplicated bacteremia or right-sided endocarditis. (LLM, conf=0.93)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“CoNS that cause PVE usually are methicillin resistant, particularly when IE develops within 1 year after surgery.182”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Coagulase-Negative Staphylococci
What the sources say
- Partly supportedcites [182] 182. Chu VH, Miro JM, Hoen B, Cabell CH, Pappas PA, Jones P, Stryjewski ME, Anguera I, Braun S, Muñoz P, Commerford P, Tornos P, Francis J, Oyonarte M, Selton-Suty C, Morris AJ, Habib G, Almirante B, Sexton DJ, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis-Prospective Cohort Study Group. Coagulase-negative staphylococcal prosthetic valve endocarditis: a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study. Heart. 2009;95:570-576. doi: 10.1136/hrt.2008.152975. sourceExperimental — accuracy not yet measured
The Results report methicillin resistance in 68% of CoNS strains, supporting 'usually methicillin resistant.' But the Results and Discussion say resistance was high regardless of time since valve implantation; they do not support the suggestion that it was particularly high when endocarditis developed within one year. (LLM, conf=0.88)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the registrational trial, 13 however, this agent performed as well as vancomycin or β-lactams in treating septic pulmonary emboli caused by S aureus, reflecting the distinct pathogenesis of this syndrome as opposed to traditional pneumonia.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Therapy of MSSA IE in Patients Allergic to or Intolerant of β-Lactams
What the sources say
- Partly supportedcites [13] 13. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-665. doi: 10.1056/NEJMoa053783. sourceExperimental — accuracy not yet measured
The Patients table reports septic pulmonary emboli at baseline in 10 daptomycin recipients and 13 standard-therapy recipients. The Outcome section finds daptomycin noninferior overall for S. aureus bacteremia and endocarditis, but does not report outcomes specifically for patients with septic pulmonary emboli. It therefore does not establish that the treatments performed equally well for that syndrome. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, linezolid-resistant strains have developed during treatment.201”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Linezolid
What the sources say
- Supportedcites [201] source
The Discussion states that de novo linezolid resistance has been documented in isolates from the same patient after linezolid exposure. This supports the claim that resistant strains have developed during treatment. (LLM, conf=0.91)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A number of in vitro evaluations [214][215][216] suggested that ampicillin and ceftaroline in combination with daptomycin demonstrate the greatest synergistic activity compared with other β-lactam-daptomycin combinations.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Daptomycin
What the sources say
- Not checked — no full text of the sourcecites [214] source
- Partly supportedcites [215] sourceExperimental — accuracy not yet measured
The Results report that ampicillin and ceftaroline each showed in vitro synergy with daptomycin against the daptomycin-susceptible VRE strain, whereas ceftriaxone did not. But only ceftaroline showed synergy against the daptomycin-nonsusceptible strain. The paper therefore does not support presenting both combinations as the greatest across strains or compared with β-lactam combinations beyond those tested. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [216] source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Olaison and Schadewitz 189 in Sweden reported a 5-year prospective study of 78 cases of enterococcal IE treated with a β-lactam and an aminoglycoside.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Short-Course (≈2-Week) Gentamicin Therapy
What the sources say
- Partly supportedcites [189] 189. Olaison L, Schadewitz K; Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis. Enterococcal endo- carditis in Sweden, 1995-1999: can shorter therapy with aminogly- cosides be used? Clin Infect Dis. 2002;34:159-166. doi: 10.1086/ 338233. sourceExperimental — accuracy not yet measured
The paper describes a five-year prospective study in Sweden, but reports 93 definite enterococcal IE episodes, not 78; 78 is the number caused by E. faecalis (opening summary, p. 1; Results, p. 2). The Results (pp. 3, 5) also show that treatment varied: some patients received vancomycin, and seven received no aminoglycoside. Thus the stated treatment does not describe all cases. (LLM, conf=0.93)
plainn = 78- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, ampicillin-sulbactam may be considered a treatment option, although HACEK resistance to this agent in vitro has been described.219”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > HACEK Microorganisms
What the sources say
- Supportedcites [219] source
The results passage (section labeled Abstract in our copy; article p. 1989–1991) reports that two clinical HACEK isolates were resistant to ampicillin-sulbactam. The discussion (section labeled C. hominis) also says the combination was not universally active in vitro. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Additional laboratory screening is required to identify the causes of culture-negative IE. 233”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Supportedcites [233] 233. Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr, Bourbeau P, Carroll KC, Kehl SC, Dunne WM, Robinson-Dunn B, Schwartzman JD, Chapin KC, Snyder JW, Forbes BA, Patel R, Rosenblatt JE, Pritt BS. A guide to utilization of the microbiology labo- ratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013;57:e22-e121. doi: 10.1093/cid/cit278. source
The “Bloodstream Infections and Infective Endocarditis” section explains that some causes of culture-negative infective endocarditis cannot be detected by conventional blood cultures. It identifies serologic testing and, in some cases, molecular methods as ways to determine the cause. (LLM, conf=0.90)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Limitations such as referral bias and sampling bias may have affected the findings.[235][236][237]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [235] 235. Thuny F, Fournier PE, Casalta JP, Gouriet F, Lepidi H, Riberi A, Collart F, Habib G, Raoult D. Investigation of blood culture-negative early prosthetic valve endocarditis reveals high prevalence of fungi. Heart. 2010;96:743-747. doi: 10.1136/hrt.2009.181594. source
- Not checked — no full text of the sourcecites [236] 236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. Comprehensive diagnostic strategy for blood culture-negative endocardi- tis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131- 140. doi: 10.1086/653675. source
- Partly supportedcites [237] 237. Geissdörfer W, Moos V, Moter A, Loddenkemper C, Jansen A, Tandler R, Morguet AJ, Fenollar F, Raoult D, Bogdan C, Schneider T. High fre- quency of Tropheryma whipplei in culture-negative endocarditis. J Clin Microbiol. 2012;50:216-222. doi: 10.1128/JCM.05531-11. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says regional bias could not be excluded because the study included only patients from Germany, supporting a concern that its findings may be affected by bias. It does not identify referral bias; its mention of sampling error concerns negative confirmatory test results, not sampling bias in the study's findings. (LLM, conf=0.78)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“To complicate matters, the APA syndrome may develop secondary to IE. 239”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Supportedcites [239] 239. Kupferwasser LI, Hafner G, Mohr-Kahaly S, Erbel R, Meyer J, Darius H. The presence of infection-related antiphospholipid antibodies in infec- tive endocarditis determines a major risk factor for embolic events. J Am Coll Cardiol. 1999;33:1365-1371. source
In “Role of antiphospholipid antibodies in infective endocarditis” (page not provided), the authors say their findings strongly suggest that antiphospholipid syndrome in these patients was acquired and related to infective endocarditis. That supports the citing sentence’s qualified claim that it may develop secondary to IE. (LLM, conf=0.94)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Three studies that included 2 cohorts of patients with NVE and PVE and 1 cohort with NVE showed an association between early surgery and lower mortality in IE patients in general or in specific subgroups of patients such as those with heart failure or paravalvular complications.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Supportedcites [10] 10. Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG Jr, Corey GR, Chu VH, Fenely M, Pachirat O, Tan RS, Watkin R, Ionac A, Moreno A, Mestres CA, Casabé J, Chipigina N, Eisen DP, Spelman D, Delahaye F, Peterson G, Olaison L, Wang A; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121:1005-1013. doi: 10.1161/CIRCULATIONAHA.109.86 source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [11] 11. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306:2239-2247. doi: 10.1001/jama.2011.1701. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Not checked — no full text of the sourcecites [14] 14. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Hoskin TL, Mirzoyev Z, Anavekar NS, Enders F, Moustafa S, Mookadam F, Huskins WC, Wilson WR, Baddour LM. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation. 2007;115:1721-1728. doi: 10.1161/CIRCULATIONAHA.106.658831. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Since 2007, at least 3 studies 15,16,258 have documented the effect of survivor bias on the association between surgery and mortality in IE patients.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Not checked — no full text of the sourcecites [15] 15. Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, Tattevin P, Iung B, Delahaye F, Alla F; AEPEI Study Group. The impact of valve surgery on short-and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J. 2011;32:2003-2015. doi: 10.1093/eurheartj/ehp008. source
- Supportedcites [16] 16. Sy RW, Bannon PG, Bayfield MS, Brown C, Kritharides L. Survivor treat- ment selection bias and outcomes research: a case study of surgery in infective endocarditis. Circ Cardiovasc Qual Outcomes. 2009;2:469-474. doi: 10.1161/CIRCOUTCOMES.109.857938. source
This 2009 study is one of the studies cited for the statement. Its Discussion reports that correcting for survivor treatment selection bias removed the apparent association between surgery and reduced mortality in infective endocarditis; the three-study count is supported by the citations collectively, not attributed to this paper alone. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [258] 258. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Montori VM, Hoskin TL, Enders F, Huskins WC, Mookadam F, Wilson WR, Zimmerman V, Baddour LM. Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias. J Clin Epidemiol. 2010;63:130-135. doi: 10.1016/j. jclinepi.2008.06.022. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Between 2007 and 2013, at least 6 observational studies 10,11,[14][15][16]259 that adjusted for selection bias, confounding, and survivor bias were conducted.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Supportedcites [10] 10. Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG Jr, Corey GR, Chu VH, Fenely M, Pachirat O, Tan RS, Watkin R, Ionac A, Moreno A, Mestres CA, Casabé J, Chipigina N, Eisen DP, Spelman D, Delahaye F, Peterson G, Olaison L, Wang A; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121:1005-1013. doi: 10.1161/CIRCULATIONAHA.109.86 source
The Methods (Analytical Plan) identify this as an observational cohort and describe adjustments for treatment-selection bias, survivor bias, and hidden bias. The Discussion table lists the present study among observational studies comparing surgery with medical therapy. This source supports its role as one of the studies cited, rather than independently establishing the count of six. (LLM, conf=0.91)
- Supportedcites [11] 11. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306:2239-2247. doi: 10.1001/jama.2011.1701. source
This 2011 paper is one of the observational studies identified by the grouped citations, not a source for the count of six. Its Methods describe adjustment for clinical variables and use of propensity-based inverse probability weighting; the Results explicitly say these methods addressed selection bias and survivor treatment bias. The paper also acknowledges that unmeasured variables may still confound its findings. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [14] 14. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Hoskin TL, Mirzoyev Z, Anavekar NS, Enders F, Moustafa S, Mookadam F, Huskins WC, Wilson WR, Baddour LM. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation. 2007;115:1721-1728. doi: 10.1161/CIRCULATIONAHA.106.658831. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Risk stratification models such as the Society of Thoracic Surgeons Endocarditis Score are available to predict morbidity and mortality risks in IE patients after valve surgery and to assist in decision making and patient counseling.260”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Indications for Surgery
What the sources say
- Partly supportedcites [260] 260. Gaca JG, Sheng S, Daneshmand MA, O'Brien S, Rankin JS, Brennan JM, Hughes GC, Glower DD, Gammie JS, Smith PK. Outcomes for endocarditis surgery in North America: a simplified risk scoring sys- tem. J Thorac Cardiovasc Surg. 2011;141:98-106.e1-e2. doi: 10.1016/j. jtcvs.2010.09.016. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In surveys involving populationbased 1 and international multicenter cohorts, 10,11 ≈50% of both NVE and PVE patients undergo valve surgery during the active phase of IE (during initial hospitalization before completion of a full therapeutic course of antibiotics).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Partly supportedcites [10] 10. Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG Jr, Corey GR, Chu VH, Fenely M, Pachirat O, Tan RS, Watkin R, Ionac A, Moreno A, Mestres CA, Casabé J, Chipigina N, Eisen DP, Spelman D, Delahaye F, Peterson G, Olaison L, Wang A; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121:1005-1013. doi: 10.1161/CIRCULATIONAHA.109.86 sourceExperimental — accuracy not yet measured
The Results report that 720 of 1,552 patients with native valve endocarditis (46%) underwent early surgery in the international multicenter cohort. The Methods state that patients with prosthetic valves were excluded, so this paper does not support the approximately 50% figure for prosthetic valve endocarditis. (LLM, conf=0.88)
- Partly supportedcites [11] 11. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306:2239-2247. doi: 10.1001/jama.2011.1701. sourceExperimental — accuracy not yet measured
The Results (page unavailable) report surgery during the initial hospitalization for 839 patients with heart failure and 1,168 without it—approximately 49% of the 4,075-patient international multicenter cohort. The paper does not establish that approximately 50% of native-valve patients and 50% of prosthetic-valve patients each underwent surgery, nor does this cohort establish the rate in population-based surveys. (LLM, conf=0.85)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Data from nonrandomized trials from a single-center experience 250 and an international collaboration 251 support the notion 252 that early valve surgery may not be beneficial in all patients with native or PVE caused by S aureus.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Partly supportedcites [250] 250. Desch S, Freund A, de Waha S, Eitel I, Lurz P, Stiermaier T, Fuernau G, Schuler G, Thiele H. Outcome in patients with left-sided native- valve infective endocarditis and isolated large vegetations. Clin Cardiol. 2014;37:626-633. doi: 10.1002/clc.22315. sourceExperimental — accuracy not yet measured
The Abstract and Discussion report that surgery appeared to be associated with higher mortality in patients with left-sided native-valve endocarditis and isolated large vegetations, supporting the qualified notion that surgery may not benefit every patient. The study did not examine prosthetic-valve endocarditis or establish the surgery outcome specifically for patients with S. aureus infection; it included S. aureus blood-culture status as a predictor of mortality. Page numbers are not available for the decisive Abstract and Discussion passages in our copy. (LLM, conf=0.88)
- Supportedcites [251] 251. Chirouze C, Alla F, Fowler VG Jr, Sexton DJ, Corey GR, Chu VH, Wang A, Erpelding ML, Durante-Mangoni E, Fernández-Hidalgo N, Giannitsioti E, Hannan MM, Lejko-Zupanc T, Miró JM, Muñoz P, Murdoch DR, Tattevin P, Tribouilloy C, Hoen B; ICE Prospective Investigators. Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. Clin Infect Dis. 2015;60:741- 749. doi: 10.1093/cid/ciu871. source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Not checked — no full text of the sourcecites [252] 252. Karchmer AW, Bayer AS. Editorial commentary: surgical therapy for Staphylococcus aureus prosthetic valve endocarditis: proceed with cau- tion (caveat emptor). Clin Infect Dis. 2015;60:750-752. doi: 10.1093/ cid/ciu877. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The high rates of postoperative morbidity and mortality seen in earlier studies [265][266][267] have resulted in a reluctance to refer patients with IE and acute stroke for immediate valve surgery.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Supportedcites [265] 265. Maruyama M, Kuriyama Y, Sawada T, Yamaguchi T, Fujita T, Omae T. Brain damage after open heart surgery in patients with acute cardioem- bolic stroke. Stroke. 1989;20:1305-1310. source
The Abstract reports three postoperative deaths and one patient who became comatose among 14 patients operated on soon after cerebral embolism; three of the four with clinical aggravation had septic embolism. The Discussion says surgery after recent infarction was considered to carry a high risk of serious neurologic complications and was even considered contraindicated, supporting the described reluctance. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [266] 266. Gillinov AM, Shah RV, Curtis WE, Stuart RS, Cameron DE, Baumgartner WA, Greene PS. Valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg. 1996;61:1125-1129. source
- Partly supportedcites [267] 267. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cere- bral complications: multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995;110:1745-1755. sourceExperimental — accuracy not yet measured
The section on mortality of cardiac surgery reports earlier operative mortality of 10%–37% for early valve replacement. The introduction also describes concern about operating after a cerebrovascular event because bypass could worsen brain injury. The paper does not establish that those earlier rates caused clinicians to be reluctant to refer patients for immediate surgery. Page numbers are unavailable in our copy. (LLM, conf=0.83)
plaindirectn = 181- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Despite the availability of new studies, the indications for surgery have not changed appreciably over time.18”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Could not verifycites [18] 18. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL; ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treat- ment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC): endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemother sourceExperimental — accuracy not yet measured
The section on indications and optimal timing of surgery lists heart failure, uncontrolled infection, and prevention of embolic events as the three main indications for early surgery (page unavailable). It does not compare surgical indications across time or say whether new studies changed them. Searches for unchanged indications and comparisons with previous guidelines found no passage addressing that temporal claim. (LLM, conf=0.70)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“Fifty of the 61 patients (81.9%) with CT-verified preoperative stroke survived cardiac surgery.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Supportedcites [270] 270. Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, Laufer G, Müller LC. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094-2099. doi: 10.1161/01. STR.0000229894.28591.3f. source
The Postoperative Neurological Recovery section states that 50 of 61 patients with CT-verified preoperative stroke survived cardiac surgery (81.9%). (LLM, conf=0.95)
plainn = 61- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In a multicenter study of patients with hemorrhagic stroke, mortality was higher when surgery was performed within 4 weeks of the hemorrhagic event compared with later surgery (75% versus 40%, respectively).274”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Partly supportedcites [274] sourceExperimental — accuracy not yet measured
The Surgery and Neurological Complications section reports 3 deaths among 4 patients operated on within 2 weeks (75%) and 2 among 5 operated on after 21 days (40%). Table 6 uses the same time groups; the study does not establish the claimed comparison of surgery within 4 weeks versus later surgery. (LLM, conf=0.90)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Investigations have suggested better outcomes for IE patients with ischemic stroke who undergo early cardiac surgery.[268][269][270][271][272]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Partly supportedcites [268] 268. Cooper HA, Thompson EC, Laureno R, Fuisz A, Mark AS, Lin M, Goldstein SA. Subclinical brain embolization in left-sided infective endocarditis: results from the Evaluation by MRI of the Brains of Patients With Left-Sided Intracardiac Solid Masses (EMBOLISM) pilot study. Circulation. 2009;120:585-591. doi: 10.1161/CIRCULATIONAHA. 108.834432. sourceExperimental — accuracy not yet measured
Clinical Outcomes (p. 4) reports lower mortality among surgical patients in the overall left-sided infective endocarditis cohort, and the Discussion (p. 6) says early surgery was associated with reduced mortality. For patients with clinical stroke or subclinical brain embolization, the paper reports no postoperative neurological events after early surgery, but it does not establish better survival specifically for patients with ischemic stroke who undergo early surgery. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [269] 269. Hosono M, Sasaki Y, Hirai H, Sakaguchi M, Nakahira A, Seo H, Morisaki A, Suehiro S. Considerations in timing of surgical intervention for infec- tive endocarditis with cerebrovascular complications. J Heart Valve Dis. 2010;19:321-325.
- Partly supportedcites [270] 270. Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, Laufer G, Müller LC. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094-2099. doi: 10.1161/01. STR.0000229894.28591.3f. sourceExperimental — accuracy not yet measured
The Discussion reports favorable neurological recovery after cardiac surgery and recommends early surgery for uncomplicated ischemic stroke. But Postoperative Neurological Recovery says surgery within four days versus later was not a relevant factor for neurological complications or recovery, so this study does not establish better outcomes from earlier surgery. (LLM, conf=0.85)
hedgedconditionaln = 65- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Full neurological recovery was achieved in 70% of 50 stroke patients.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Supportedcites [270] 270. Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, Laufer G, Müller LC. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094-2099. doi: 10.1161/01. STR.0000229894.28591.3f. source
The Postoperative Neurological Recovery section states that 35 of 50 stroke patients (70%) achieved full neurological recovery. These 50 patients were survivors of cardiac surgery after infective-endocarditis-related stroke. (LLM, conf=0.95)
plainn = 50- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Of note, 2 independent studies have confirmed that the rate of embolic events decreases dramatically during and after the first 2 to 3 weeks of successful antibiotic therapy.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [58] 58. Steckelberg JM, Murphy JG, Ballard D, Bailey K, Tajik AJ, Taliercio CP, Giuliani ER, Wilson WR. Emboli in infective endocarditis: the prognos- tic value of echocardiography. Ann Intern Med. 1991;114:635-640. Doi: 10.7326/0003-4819-114-8-635. source
- Supportedcites [278] source
The Results report that 65% of embolic events after antibiotics began occurred in the first two weeks; the Conclusions likewise say most emboli occurred within that period. The Discussion states that embolism rates decrease dramatically once antibiotic therapy is initiated. This paper supports the claim as one of the two studies, though it does not itself establish the second study's findings. (LLM, conf=0.85)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Other studies [6][7][8] suggest that the risk of neurological deterioration during cardiac surgery after a stroke is lower than previously assumed, particularly in patients with silent cerebrovascular emboli.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Not checked — no full text of the sourcecites [6] 6. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS; ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress [published correction appears in JAMA. 2005;294:900]. JAMA. 2005;293:3012-3021. doi: 10.1001/jama.293.24.3012. source
- Not checked — no full text of the sourcecites [7] 7. Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alla F, Duval X, Hoen B; AEPEI Study Group. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54:1230-1239. doi: 10.1093/cid/cis199. source
- Could not verifycites [8] 8. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infec- tive endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463- 473. doi: 10.1001/archinternmed.2008.603. sourceExperimental — accuracy not yet measured
The Results and In-Hospital Mortality sections (page numbers unavailable) report that surgery was associated with lower in-hospital mortality in patients with infective endocarditis. They do not assess neurological deterioration during surgery after stroke or outcomes in patients with silent cerebrovascular emboli. Searches for those terms found no passage addressing the claim. (LLM, conf=0.76)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several studies with TTE have demonstrated a trend toward higher embolic rates with left-sided vegetations >1 cm in diameter.55”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Partly supportedcites [55] 55. Sanfilippo AJ, Picard MH, Newell JB, Rosas E, Davidoff R, Thomas JD, Weyman AE. Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol. 1991;18:1191-1199. sourceExperimental — accuracy not yet measured
In Echocardiographic Findings (page unavailable), the paper says vegetation size helps identify patients with native left-sided valve endocarditis at risk of complications, and it includes embolization among the complications assessed. The passages do not establish a higher embolic rate specifically for vegetations greater than 1 cm. (LLM, conf=0.79)
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Systemic embolization occurs in 22% to 50% of cases of IE. 55,57,[274][275][276][277]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Could not verifycites [55] 55. Sanfilippo AJ, Picard MH, Newell JB, Rosas E, Davidoff R, Thomas JD, Weyman AE. Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol. 1991;18:1191-1199. sourceExperimental — accuracy not yet measured
The paper’s clinical-event definitions include systemic embolization, but the passages available from our copy do not give its frequency. Searches for the 22%–50% range and for embolization rates in the Results and Table 2 did not locate a supporting figure. (LLM, conf=0.72)
- Not checked — no full text of the sourcecites [57] 57. Mügge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infec- tive endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol. 1989;14:631-638. doi: 10.1016/0735-1097(89)90104-6. source
- Could not verifycites [274] sourceExperimental — accuracy not yet measured
The Discussion reports 25% neurological complications and 19% vascular events in this cohort, not a rate of systemic embolization. A search for the 22%–50% range and for systemic embolization incidence found no passage in our copy that supports the claimed range. (LLM, conf=0.73)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“a randomized trial compared oral aspirin 325 mg/d with placebo in 115 IE patients.288”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Anticoagulation
What the sources say
- Supportedcites [288] 288. Chan KL, Dumesnil JG, Cujec B, Sanfilippo AJ, Jue J, Turek MA, Robinson TI, Moher D; Investigators of the Multicenter Aspirin Study in Infective Endocarditis. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol. 2003;42:775-780. source
The Intervention and outcomes section states that eligible patients were randomized to aspirin 325 mg/day or placebo; the paper describes both treatments as tablets. The Results section reports 115 randomized patients, with 60 assigned to aspirin and 55 to placebo. Page numbers are not available in the supplied copy. (LLM, conf=0.94)
plainn = 115- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The benefits of early surgery were demonstrated in the prospective, randomized trial 12 that was discussed earlier in this document.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Partly supportedcites [12] 12. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA. Infective endocarditis: diagno- sis, antimicrobial therapy, and management of complications: a state- ment for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American sourceExperimental — accuracy not yet measured
The Risk of Embolization section says the benefit of surgery to avoid catastrophic embolic events is greatest early in the treatment of infective endocarditis. It does not say that a prospective randomized trial demonstrated that benefit; that part of the claim is unsupported by this source. (LLM, conf=0.84)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The traditional indication for valvular surgery for IE to avoid embolization has been ≥2 major embolic events.284”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Partly supportedcites [284] sourceExperimental — accuracy not yet measured
The Discussion (page unavailable in our copy) says recurrent embolic events are a recognized indication for surgery in infective endocarditis, which supports the idea of more than one event. It does not specify that the events must be major or state a formal threshold of at least two major events. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Only aortic valve involvement and current IDU have been prospectively identified as independent risk factors for perivalvular abscess.297”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Partly supportedcites [297] 297. Middlemost S, Wisenbaugh T, Meyerowitz C, Teeger S, Essop R, Skoularigis J, Cronje S, Sareli P. A case for early surgery in native left- sided endocarditis complicated by heart failure: results in 203 patients. J Am Coll Cardiol. 1991;18:663-667. sourceExperimental — accuracy not yet measured
The Results (page unavailable in our copy) report abscesses in 38 of 110 patients with aortic valve infection, compared with 1 of 30 with mitral valve infection. This supports an association with aortic valve involvement, but the passages do not identify it as an independent risk factor or identify current injection drug use as one. Searches for drug use, prospective analysis, and independent risk factors found no supporting passage. (LLM, conf=0.87)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The size of vegetations is not helpful for predicting perivalvular extension.297”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Could not verifycites [297] 297. Middlemost S, Wisenbaugh T, Meyerowitz C, Teeger S, Essop R, Skoularigis J, Cronje S, Sareli P. A case for early surgery in native left- sided endocarditis complicated by heart failure: results in 203 patients. J Am Coll Cardiol. 1991;18:663-667. sourceExperimental — accuracy not yet measured
The Methods describe identifying vegetations by echocardiography, and the Results and Discussion report extensive infection and abscesses. None of the passages found assesses whether vegetation size predicts perivalvular extension (searched for vegetation size, abscesses, and extensive infection). Page numbers were not available in our copy. (LLM, conf=0.72)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“Homografts have a constant but low incidence rate of IE. 312”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Supportedcites [312] source
The Abstract states that allograft aortic valve replacement has a low, constant risk of recurrent endocarditis. The Discussion likewise describes a low, constant hazard for allografts; these passages support the claim about homografts, though the study specifically discusses infection after valve replacement. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The sensitivity of TTE for detecting perivalvular abscess is low (18% to 63% in prospective and retrospective studies, respectively).305,306”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Partly supportedcites [305] sourceExperimental — accuracy not yet measured
The PREVIOUS ECHOCARDIOGRAPHIC STUDIES section reports low TTE sensitivity for detecting aortic root abscess, but gives a range of 18%–67%, not 18%–63%, and does not assign those values to prospective and retrospective studies. The PREOPERATIVE ECHOCARDIOGRAPHIC FINDINGS section reports 36% sensitivity in this paper’s own patients. Page numbers were not available in our copy. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [306] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A small number of patients with periannular extension of infection or myocardial abscess may be treated successfully without surgical intervention.307,308”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Partly supportedcites [307] sourceExperimental — accuracy not yet measured
The Discussion reports successful antibiotic treatment of a mitral anular (perivalvular) abscess, supporting the claim that some patients can avoid surgery for the abscess. It does not report a medically cured myocardial abscess. The patient also underwent a subxiphoid pericardiectomy for a pericardial effusion, so the unqualified phrase “without surgical intervention” is not accurate for this case. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [308] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Current evidence suggests that poor oral hygiene and periodontal diseases, not dental office procedures, are likely to be responsible for the vast majority of cases of IE that originate in the mouth.328”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Dental Management
What the sources say
- Supportedcites [328] source
In the article text (p. 60), Lockhart calls bacteremia arising from dental plaque and inflamed periodontal tissues the main source of oral bacteria implicated in IE. He also says poor oral hygiene and periodontal disease are far greater risk factors for oral bacteria-related IE than invasive dental procedures, supporting the claim's hedged comparison. (LLM, conf=0.91)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A large, prospective study demonstrated a strong association between 3 indexes of oral hygiene and gingival disease and the incidence of bacteremia from IE-related species.327”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Dental Management
What the sources say
- Supportedcites [327] source
The Participants and Methods section describes a three-year study that assessed plaque, calculus, and gingivitis indexes. The Results report strong associations between oral-hygiene measures, bleeding with toothbrushing, and IE-related bacteremia in the toothbrushing group. The association was not found in the extraction group. (LLM, conf=0.88)
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“valve lesions in right-sided IE usually do not create the peripheral emboli and immunological vascular phenomena that can result from left-sided valvular involvement.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Diagnosis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Acute IE may evolve too quickly for the development of immunological vascular phenomena, which are more characteristic of the later stages of the more insidious subacute form of untreated IE.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Diagnosis
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The diagnosis of IE is straightforward in the minority of patients who present with a consistent history and classic oslerian manifestations: sustained bacteremia or fungemia, evidence of active valvulitis, peripheral emboli, and immunological vascular phenomena.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Diagnosis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“S aureus is now the most common causative organism in most of the industrialized world.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Follow-up in these reclassified patients documented the specificity of this diagnostic schema because no patients developed IE during the subsequent 12 weeks of observation.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In an analysis of 262 patients at the Duke University Medical Center who had hospital-acquired S aureus bacteremia, 34 (13%) were subsequently diagnosed with definite IE.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
plainn = 262- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“the incidence of IE caused by Staphylococcus aureus has increased”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In most patients, however, the”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Diagnosis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“IE caused by Bartonella and Chlamydia species often are indistinguishable in serological test results because of cross-reactions.41”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Not checked — no full text of the sourcecites [41] 41. Raoult D, Fournier PE, Drancourt M, Marrie TJ, Etienne J, Cosserat J, Cacoub P, Poinsignon Y, Leclercq P, Sefton AM. Diagnosis of 22 new cases of Bartonella endocarditis [published correction appears in Ann Intern Med. 1997;127:249]. Ann Intern Med. 1996;125:646-652. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Low sensitivity is a major limitation of PCR unless cardiac valvular tissue is available for testing.[42][43][44][45]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Not matchedcites [42][43][44][45]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
None of the sources cited for this claim have been checked yet.
In the paper
“Epidemiological surveys from France and the International Collaboration on Endocarditis have confirmed that the epidemiological profile of IE has changed substantially.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In a study of 100 consecutive cases of pathologically proven native valve IE (NVE), inclusion of these additional parameters with the existing Duke minor criteria resulted in a 10% increase in the frequency of cases being deemed clinically definite, with no loss of specificity.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
plaindirectn = 100- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The greatest risk of embolic complications appears to occur with large (≥10 mm) vegetations on the anterior mitral leaflet.58”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Echocardiography
What the sources say
- Not checked — no full text of the sourcecites [58] 58. Steckelberg JM, Murphy JG, Ballard D, Bailey K, Tajik AJ, Taliercio CP, Giuliani ER, Wilson WR. Emboli in infective endocarditis: the prognos- tic value of echocardiography. Ann Intern Med. 1991;114:635-640. Doi: 10.7326/0003-4819-114-8-635. source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“MRI has had a major impact on IE diagnosis and management, especially as a tool to detect cerebral embolic events, many of which are clinically silent.69”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > 3D Echocardiography and Other Imaging Modalities
What the sources say
- Not checked — no full text of the sourcecites [69] 69. Duval X, Iung B, Klein I, Brochet E, Thabut G, Arnoult F, Lepage L, Laissy JP, Wolff M, Leport C; IMAGE (Resonance Magnetic Imaging at the Acute Phase of Endocarditis) Study Group. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocardi- tis: a prospective study. Ann Intern Med. 2010;152:497-504, W175. doi: 10.7326/0003-4819-152-8-201004200-00006. source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The ability of echocardiographic features to predict embolic events is limited.[55][56][57]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Echocardiography
What the sources say
- Not matchedcites [55][56][57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“Both TEE and TTE may produce false-negative results if vegetations are small or have embolized.53”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Echocardiography
What the sources say
- Not checked — no full text of the sourcecites [53] 53. Bayer AS. Infective endocarditis. Clin Infect Dis. 1993;17:313-320; quiz 321. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“For example, in an in vitro PD model, the activity of vancomycin against heterogeneous vancomycin-intermediate S aureus (hVISA) and non-hVISA isolates was reduced in the presence of a high inoculum amount (10 8 colony-forming units per milliliter).75”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Inoculum Effect
What the sources say
- Not checked — no full text of the sourcecites [75] 75. Rose WE, Leonard SN, Rossi KL, Kaatz GW, Rybak MJ. Impact of inoc- ulum size and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) on vancomycin activity and emergence of VISA in an in vitro pharmacodynamic model. Antimicrob Agents Chemother. 2009;53:805-807. doi: 10.1128/AAC.01009-08. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Investigation in adults has shown TEE to be significantly more sensitive than TTE for the detection of vegetations and abscesses.47”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Echocardiography
What the sources say
- Not checked — no full text of the sourcecites [47] 47. Reynolds HR, Jagen MA, Tunick PA, Kronzon I. Sensitivity of transtho- racic versus transesophageal echocardiography for the detection of native valve vegetations in the modern era. J Am Soc Echocardiogr. 2003;16:67- 70. doi: 10.1067/mje.2003.43. source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“On the basis of these data, specific serological data as a surrogate marker for positive blood cultures have now been included in the Duke criteria.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
plainn = 20- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In the original Duke criteria, bacteremia resulting from S aureus or enterococci was considered to fulfill a major criterion only if it was community acquired because ample literature suggested that this parameter was an important surrogate marker for underlying IE.27”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Not checked — no full text of the sourcecites [27] 27. Bayer AS, Ward JI, Ginzton LE, Shapiro SM. Evaluation of new clini- cal criteria for the diagnosis of infective endocarditis. Am J Med. 1994;96:211-219. source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The emergence of S aureus IE is due in part to the increasing importance of healthcare contact as a leading risk associated with infection.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Abstract
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The Duke criteria incorporated echocardiographic findings into the diagnostic strategy (Tables 2 and 3; see the Echocardiography section).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Diagnosis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“the rapid detection of pathogens from valve tissue from patients undergoing surgery for IE by polymerase chain reaction (PCR) has been validated.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In 1994, Durack and colleagues 23 from the Duke University Medical Center proposed a diagnostic schema that stratified patients with suspected IE into 3 categories: definite, possible, and rejected cases (Tables 2 and 3).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Diagnosis
What the sources say
- Not checked — no full text of the sourcecites [23] 23. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infec- tive endocarditis: utilization of specific echocardiographic findings: Duke Endocarditis Service. Am J Med. 1994;96:200-209. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Several rigorously conducted observational studies 11,[14][15][16] and a randomized, controlled trial 17 have examined the impact and timing of valve surgery in IE management.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Abstract
What the sources say
- Not matchedcites 11,[14][15][16]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [17] 17. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW. Early surgery versus conven- tional treatment for infective endocarditis. N Engl J Med. 2012;366:2466- 2473. doi: 10.1056/NEJMoa1112843. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Importantly, fluoroquinolones and aminoglycoside antibiotics are less affected by the size of the inoculum because of their different mechanisms of bactericidal activity. 81,82”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Inoculum Effect
What the sources say
- Not checked — no full text of the sourcecites [81] 81. LaPlante KL, Woodmansee S. Activities of daptomycin and vancomy- cin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. Antimicrob Agents Chemother. 2009;53:3880-3886. doi: 10.1128/AAC.00134-09. source
- Not checked — no full text of the sourcecites [82] 82. Mizunaga S, Kamiyama T, Fukuda Y, Takahata M, Mitsuyama J. Influence of inoculum size of Staphylococcus aureus and Pseudomonas aerugi- nosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems. J Antimicrob Chemother. 2005;56:91-96. doi: 10.1093/jac/ dki163. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, bacteria that are otherwise killed at low densities by bactericidal antibiotics such as penicillins can be relatively resistant to or tolerant of their bactericidal effect in dense populations.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Inoculum Effect
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, prolonged, parenteral, bactericidal therapy is required for attempted infection cure.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Therapeutic Principles
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Host characteristics such as impaired immunity contribute to challenges in treating IE.
- Rests on an assumption: Antibiotics may fail to eradicate infection as a result of increased binding of the drug to serum proteins, perturbations of antibiotic penetration into the vegetation, and unique antibiotic PK/PD features.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, on the basis of the weight of clinical evidence involving nearly 2000 patients in the current literature, it appears that patients suspected of having IE should be clinically evaluated, with the modified Duke criteria as the primary diagnostic schema.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
hedgedn = 2,000- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“cost-effectiveness calculations suggest that TEE should be the first examination in adults with suspected IE (Table 4), particularly in the setting of staphylococcal bacteremia, 49,50”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Echocardiography
What the sources say
- Not checked — no full text of the sourcecites [49] 49. Heidenreich PA, Masoudi FA, Maini B, Chou TM, Foster E, Schiller NB, Owens DK. Echocardiography in patients with suspected endocarditis: a cost-effectiveness analysis. Am J Med. 1999;107:198-208. source
- Not checked — no full text of the sourcecites [50] 50. Lindner JR, Case RA, Dent JM, Abbott RD, Scheld WM, Kaul S. Diagnostic value of echocardiography in suspected endocarditis: an evaluation based on the pretest probability of disease. Circulation. 1996;93:730-736. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because IE is a heterogeneous disease with highly variable clinical presentations, the use of these criteria alone will never suffice.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, the effective minimum inhibitory concentration (MIC) at the site of infection with bacterial densities of 10 8 to 10 11 colony-forming units per 1 g tissue can be much higher than anticipated by in vitro susceptibility tests that use a standard inoculum (10 5.5 colony-forming units per milliliter).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Inoculum Effect
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Data from animal models of IE and clinical investigations support the need for bactericidal antibiotics to sterilize vegetations in IE with high bacterial densities.89”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Bactericidal Drugs
What the sources say
- Not checked — no full text of the sourcecites [89] 89. Hunter TH. Speculations on the mechanism of cure of bacterial endocar- ditis. J Am Med Assoc. 1950;144:524-527. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Stationary-phase organisms have been associated with a loss of penicillin-binding proteins that are the active target sites required for β-lactam antibacterial activity.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Inoculum Effect
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Prolonged therapy is necessary because of the high bacterial densities within vegetations and the relatively slow bactericidal activity of some antibiotics such as β-lactams and vancomycin.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Duration of Antimicrobial Therapy
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“High inocula are also more likely to have antibiotic-resistant subpopulations that can emerge in the setting of antibiotic therapy.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Inoculum Effect
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“In each study, including one in which >70% of patients were HIV seropositive, 150 cure rates were >90%.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Right-Sided IE in IDUs
What the sources say
- Not checked — no full text of the sourcecites [150] 150. Heldman AW, Hartert TV, Ray SC, Daoud EG, Kowalski TE, Pompili VJ, Sisson SD, Tidmore WC, vom Eigen KA, Goodman SN, Lietman PS, Petty BG, Flexner C. Oral antibiotic treatment of right-sided staphy- lococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med. 1996;101:68-76. source
- Not checked — no full text of the sourcecites [151] 151. Dworkin RJ, Lee BL, Sande MA, Chambers HF. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with cipro- floxacin and rifampicin. Lancet. 1989;2:1071-1073. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“For example, in IDUs with uncomplicated right-sided S aureus IE (no evidence of renal failure, extrapulmonary metastatic infections, aortic or mitral valve involvement, meningitis, or infection by MRSA), combined short-course (2 weeks) β-lactam plus aminoglycoside therapy was highly effective in several studies.91,92,148”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Right-Sided IE in IDUs
What the sources say
- Not checked — no full text of the sourcecites [91] 91. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med. 1988;109:619-624. source
- Not checked — no full text of the sourcecites [92] 92. Ribera E, Gómez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez- Alujas T, Almirante B, Ocaña I, Pahissa A. Effectiveness of cloxacil- lin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis: a randomized, controlled trial. Ann Intern Med. 1996;125:969-974. source
- Not checked — no full text of the sourcecites [148] 148. Fortún J, Navas E, Martínez-Beltrán J, Pérez-Molina J, Martín-Dávila P, Guerrero A, Moreno S. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glyco- peptides in combination with gentamicin. Clin Infect Dis. 2001;33:120- 125. doi: 10.1086/320869. source
boosteddirectn = 92- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“The penetration of antibiotics is a significant issue in the treatment of IE because cardiac vegetations, which are composed of layers of fibrin and platelets, pose a considerable mechanical barrier between the antibiotic and the embedded targeted microorganisms.94,95”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Drug Penetration
What the sources say
- Not checked — no full text of the sourcecites [94] 94. Carbon C, Crémieux AC, Fantin B. Pharmacokinetic and pharmacody- namic aspects of therapy of experimental endocarditis. Infect Dis Clin North Am. 1993;7:37-51. source
- Not checked — no full text of the sourcecites [95] 95. Cremieux AC, Maziere B, Vallois JM, Ottaviani M, Azancot A, Raffoul H, Bouvet A, Pocidalo JJ, Carbon C. Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography. J Infect Dis. 1989;159:938-944. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In contrast, short-course regimens with glycopeptides (teicoplanin or vancomycin) plus gentamicin appeared to be less effective for right-sided S aureus IE caused by either MSSA or MRSA strains.148”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Right-Sided IE in IDUs
What the sources say
- Not checked — no full text of the sourcecites [148] 148. Fortún J, Navas E, Martínez-Beltrán J, Pérez-Molina J, Martín-Dávila P, Guerrero A, Moreno S. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glyco- peptides in combination with gentamicin. Clin Infect Dis. 2001;33:120- 125. doi: 10.1086/320869. source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Furthermore, combination therapy increased the frequency of gentamicin-associated nephrotoxicity.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > IE in Non-IDUs
What the sources say
- Not checked — no full text of the sourcecites [153] 153. Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to paren- teral drugs and in nonaddicts: a prospective study. Ann Intern Med. 1982;97:496-503. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, glycopeptide therapy for MRSA right-sided IE may require more prolonged treatment regimens.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Right-Sided IE in IDUs
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“For example, 1 study showed that a 2-week monotherapy regimen of intravenous cloxacillin was equivalent to cloxacillin plus gentamicin administered for 2 weeks.92”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Right-Sided IE in IDUs
What the sources say
- Not checked — no full text of the sourcecites [92] 92. Ribera E, Gómez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez- Alujas T, Almirante B, Ocaña I, Pahissa A. Effectiveness of cloxacil- lin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis: a randomized, controlled trial. Ann Intern Med. 1996;125:969-974. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“An increasing body of evidence suggests an association between high (but still susceptible on the basis of the Clinical and Laboratory Standards Institute definition) vancomycin MICs in S aureus and worse clinical outcome in both MRSA infections treated with vancomycin 140”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > S aureus
What the sources say
- Not checked — no full text of the sourcecites [140] 140. van Hal SJ, Lodise TP, Paterson DL. The clinical significance of van- comycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis. 2012;54:755-771. doi: 10.1093/cid/cir935. source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“S aureus is the most common cause of IE in much of the developed world.[6][7][8]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > S aureus
What the sources say
- Not matchedcites [6][7][8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“Importantly, this association between higher vancomycin MIC in infecting MSSA and worse clinical outcomes among patients treated with antistaphylococcal penicillins (not vancomycin) was externally validated in a large cohort of patients with MSSA IE. 142”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > S aureus
What the sources say
- Not checked — no full text of the sourcecites [142] 142. Cervera C, Castañeda X, de la Maria CG, del Rio A, Moreno A, Soy D, Pericas JM, Falces C, Armero Y, Almela M, Ninot S, Pare JC, Mestres CA, Gatell JM, Marco F, Miro JM; Hospital Clinic Endocarditis Study Group. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis. Clin Infect Dis. 2014;58:1668-1675. doi: 10.1093/cid/ciu183. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“The efficacy of antimicrobial drugs varies, depending on the degree of penetration into the vegetation, pattern of distribution within the vegetation, and vegetation size. 96,97”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Drug Penetration
What the sources say
- Not checked — no full text of the sourcecites [96] 96. Crémieux AC, Mazière B, Vallois JM, Ottaviani M, Bouvet A, Pocidalo JJ, Carbon C. Ceftriaxone diffusion into cardiac fibrin vegetation: quali- tative and quantitative evaluation by autoradiography. Fundam Clin Pharmacol. 1991;5:53-60. source
- Not checked — no full text of the sourcecites [97] 97. Cremieux AC, Saleh-Mghir A, Vallois JM, Maziere B, Muffat-Joly M, Devine C, Bouvet A, Pocidalo JJ, Carbon C. Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradio- graphic diffusion pattern of [14C]temafloxacin in cardiac vegetations. Antimicrob Agents Chemother. 1992;36:2216-2221. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Data from >70 million hospitalizations in the United States suggest that rates of S aureus IE have increased significantly relative to other causes of IE. 3”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > S aureus
What the sources say
- Not matchedcites [3] 3. Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG Jr. Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008. Arch Intern Med. 2012;172:363-365. doi: 10.1001/ archinternmed.2011.1027.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“This organism is uniformly susceptible in vitro to most antibiotics.[143][144][145]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Coagulase-Negative Staphylococci
What the sources say
- Not matchedcites [143][144][145]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“Nafcillin-gentamicin therapy reduced the duration of bacteremia by ≈1 day compared with nafcillin monotherapy.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > IE in Non-IDUs
What the sources say
- Not checked — no full text of the sourcecites [153] 153. Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to paren- teral drugs and in nonaddicts: a prospective study. Ann Intern Med. 1982;97:496-503. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“and MRSA bacteremia treated with antistaphylococcal penicillins.141”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > S aureus
What the sources say
- Not checked — no full text of the sourcecites [141] 141. Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O'Sullivan MV, Anderson TL, Roberts SA, Gao W, Christiansen KJ, Coombs GW, Johnson PD, Howden BP. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacte- remia and high vancomycin minimum inhibitory concentrations. J Infect Dis. 2011;204:340-347. doi: 10.1093/infdis/jir270. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Two studies have evaluated the use of predominantly oral 4-week antibiotic regimens (featuring ciprofloxacin plus rifampin) for the therapy of uncomplicated right-sided MSSA IE in IDUs.150,151”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Right-Sided IE in IDUs
What the sources say
- Not checked — no full text of the sourcecites [150] 150. Heldman AW, Hartert TV, Ray SC, Daoud EG, Kowalski TE, Pompili VJ, Sisson SD, Tidmore WC, vom Eigen KA, Goodman SN, Lietman PS, Petty BG, Flexner C. Oral antibiotic treatment of right-sided staphy- lococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med. 1996;101:68-76. source
- Not checked — no full text of the sourcecites [151] 151. Dworkin RJ, Lee BL, Sande MA, Chambers HF. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with cipro- floxacin and rifampicin. Lancet. 1989;2:1071-1073. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These glycopeptides may be less effective because of limited bactericidal activity, poor penetration into vegetations, or increased drug clearance among IDUs.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Right-Sided IE in IDUs
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In 1 study, 92 patients provided such combination therapy had excellent outcomes, even HIV-infected patients and those who had large tricuspid valve vegetations (>10 mm in diameter).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Right-Sided IE in IDUs
What the sources say
- Not checked — no full text of the sourcecites [92] 92. Ribera E, Gómez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez- Alujas T, Almirante B, Ocaña I, Pahissa A. Effectiveness of cloxacil- lin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis: a randomized, controlled trial. Ann Intern Med. 1996;125:969-974. source
plaindirectn = 92- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, current evidence suggests that either parenteral β-lactam or daptomycin short-course therapy is adequate for the treatment of uncomplicated MSSA right-sided IE.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Right-Sided IE in IDUs
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Although there are no published studies comparing the efficacy of regimens containing streptomycin or gentamicin, a similar cure rate was reported in a single noncomparative study.197”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Streptomycin Therapy
What the sources say
- Not checked — no full text of the sourcecites [197] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Patients with ≥3 months' duration of symptoms were successfully treated with 6 weeks of therapy.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Enterococcal Endocarditis Susceptible to Penicillin, Vancomycin, and Aminoglycosides
What the sources say
- Not checked — no full text of the sourcecites [196] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The potential effectiveness of this combination may be due in part to the capacity of the β-lactam agent to alter the surface charge of the organism October 13, 2015 in a nonbactericidal mechanism, allowing enhanced surface binding of daptomycin.[169][170][171]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Additional or Adjunctive Therapies
What the sources say
- Not matchedcites [169][170][171]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“Early cardiac surgical interventions play an important role in maximizing outcomes in S aureus PVE, 186 especially in the presence of heart failure.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > S aureus
What the sources say
- Not checked — no full text of the sourcecites [186] 186. John MD, Hibberd PL, Karchmer AW, Sleeper LA, Calderwood SB. Staphylococcus aureus prosthetic valve endocarditis: optimal manage- ment and risk factors for death. Clin Infect Dis. 1998;26:1302-1309. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Daptomycin is inhibited by pulmonary surfactant 160 and thus is contraindicated in the treatment of S aureus pneumonia acquired via the aspiration route.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Therapy of MSSA IE in Patients Allergic to or Intolerant of β-Lactams
What the sources say
- Not checked — no full text of the sourcecites [160] 160. Silverman JA, Mortin LI, Vanpraagh AD, Li T, Alder J. Inhibition of dap- tomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis. 2005;191:2149-2152. doi: 10.1086/430352. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Several case series suggest that it may have utility in complicated S aureus infections, including IE. [179][180][181]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Additional or Adjunctive Therapies
What the sources say
- Not matchedcites [179][180][181]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“In the study by Gavaldà et al,190 approximately half of the patients had IE caused by highlevel aminoglycoside-resistant strains of E faecalis.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Role of Aminoglycosides in the Treatment of Patients With Enterococcal IE: Special Considerations
What the sources say
- Not checked — no full text of the sourcecites [190] 190. Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574-579. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Of note, a prospective trial in patients with IE caused by MRSA failed to demonstrate that the addition of rifampin to vancomycin either enhanced survival or reduced the duration of bacteremia compared with treatment with vancomycin alone.163”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Additional or Adjunctive Therapies
What the sources say
- Not checked — no full text of the sourcecites [163] 163. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med. 1991;115:674-680. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Although Markowitz et al 165 showed that trimethoprimsulfamethoxazole was inferior to vancomycin in the treatment of invasive S aureus infections, it is sometimes used in salvage situations.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Additional or Adjunctive Therapies
What the sources say
- Not checked — no full text of the sourcecites [165] 165. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim- sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med. 1992;117:390-398. doi: 10.7326/0003-4819-117-5-390. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“PVE, particularly when onset is within 12 months of cardiac valve implantation and an aortic valve prosthesis is involved, is frequently complicated by perivalvular or myocardial abscesses or valvular dysfunction.136”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Coagulase-Negative Staphylococci
What the sources say
- Not checked — no full text of the sourcecites [136] 136. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Paré C, Almirante B, Muñoz P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL, Selton-Suty C, Jones SB, Casabé J, Morris A, Corey GR, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of pros- thetic valve endocarditis. JAMA. 2007;297:1354-1361. doi: 10.1001/ jama.297.12.1354. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In these situations, the potential risk of attempting to complete a 4-to 6-week course of gentamicin therapy may exceed the benefit.193”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Role of Aminoglycosides in the Treatment of Patients With Enterococcal IE: Special Considerations
What the sources say
- Not checked — no full text of the sourcecites [193] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Patient outcomes with linezolid therapy for S aureus left-sided IE have generally been poor.[174][175][176]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Additional or Adjunctive Therapies
What the sources say
- Not matchedcites [174][175][176]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“The efficacy of trimethoprimsulfamethoxazole and other folate antagonists may be attenuated by thymidine release from damaged host cells (eg, at sites of tissue damage such as abscesses).166”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Additional or Adjunctive Therapies
What the sources say
- Not checked — no full text of the sourcecites [166] 166. Proctor RA. Role of folate antagonists in the treatment of methicillin- resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46:584- 593. doi: 10.1086/525536. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, aminoglycoside-containing regimens would not be effective therapy for these patients.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Role of Aminoglycosides in the Treatment of Patients With Enterococcal IE: Special Considerations
hedgedn = 272- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“In animal studies, rifampin appears to be key in the complete sterilization of foreign bodies infected by MRSA.184,185”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > S aureus
What the sources say
- Not checked — no full text of the sourcecites [184] 184. Chuard C, Herrmann M, Vaudaux P, Waldvogel FA, Lew DP. Successful therapy of experimental chronic foreign-body infection due to methi- cillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother. 1991;35:2611-2616. source
- Not checked — no full text of the sourcecites [185] 185. Lucet JC, Herrmann M, Rohner P, Auckenthaler R, Waldvogel FA, Lew DP. Treatment of experimental foreign body infection caused by meth- icillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1990;34:2312-2317. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, the usefulness of empiric combination therapy in patients with S aureus bacteremia until oxacillin susceptibility is known is uncertain.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > IE in Non-IDUs
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“An analysis of the literature, however, compared the use of empirical combination of vancomycin and antistaphylococcal β-lactam therapy with vancomycin alone and demonstrated the superiority of β-lactam-containing regimens over vancomycin monotherapy for bacteremic MSSA infections, including IE. 154”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > IE in Non-IDUs
What the sources say
- Not checked — no full text of the sourcecites [154] 154. McConeghy KW, Bleasdale SC, Rodvold KA. The empirical combina- tion of vancomycin and a β-lactam for staphylococcal bacteremia. Clin Infect Dis. 2013;57:1760-1765. doi: 10.1093/cid/cit560. source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Patients with <3 months' duration of symptoms were treated successfully with 4 weeks of antimicrobial therapy.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Enterococcal Endocarditis Susceptible to Penicillin, Vancomycin, and Aminoglycosides
What the sources say
- Not checked — no full text of the sourcecites [196] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In this situation, if the organism is susceptible to a fluoroquinolone, animal studies of therapy for foreign-body infection suggest that a fluoroquinolone can be used instead of gentamicin.184”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Coagulase-Negative Staphylococci
What the sources say
- Not checked — no full text of the sourcecites [184] 184. Chuard C, Herrmann M, Vaudaux P, Waldvogel FA, Lew DP. Successful therapy of experimental chronic foreign-body infection due to methi- cillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother. 1991;35:2611-2616. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Quinupristin-dalfopristin 177 and telavancin 178 have been used successfully as salvage therapy in selected patients with MRSA IE who clinically failed vancomycin therapy.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Additional or Adjunctive Therapies
What the sources say
- Not checked — no full text of the sourcecites [177] 177. Sander A, Beiderlinden M, Schmid EN, Peters J. Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci. Intensive Care Med. 2002;28:1157-1160. doi: 10.1007/s00134-002-1358-7. source
- Not checked — no full text of the sourcecites [178] 178. Nace H, Lorber B. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin. J Antimicrob Chemother. 2010;65:1315-1316. doi: 10.1093/jac/dkq113. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The emergence of organisms with decreased susceptibility to daptomycin was observed in ≈5% of daptomycin-treated patients.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Therapy of MSSA IE in Patients Allergic to or Intolerant of β-Lactams
What the sources say
- Not checked — no full text of the sourcecites [155] 155. Carugati M, Bayer AS, Miró JM, Park LP, Guimarães AC, Skoutelis A, Fortes CQ, Durante-Mangoni E, Hannan MM, Nacinovich F, Fernández- Hidalgo N, Grossi P, Tan RS, Holland T, Fowler VG Jr, Corey RG, Chu VH; International Collaboration on Endocarditis. High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Antimicrob Agents Chemother. 2013;57:6213-6222. doi: 10.1128/AAC.01563-13. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In the study by Fernández-Hidalgo et al, 191 26% of the 272 patients had high-level aminoglycoside-resistant strains of E faecalis.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Role of Aminoglycosides in the Treatment of Patients With Enterococcal IE: Special Considerations
What the sources say
- Not checked — no full text of the sourcecites [191] 191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treat- ing Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261-1268. doi: 10.1093/cid/cit052. 192. source
plainn = 272- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In summary, there are insufficient data to recommend monotherapy with daptomycin for the treatment of multidrugresistant enterococcal IE.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Daptomycin
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Mave et al 203 reported cure in 2 of 3 patients with E faecium IE with linezolid.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Linezolid
What the sources say
- Not checked — no full text of the sourcecites [203] source
plaindirectn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A smaller study by this group compared ceftriaxone-ampicillin therapy of aminoglycoside-susceptible with high-level aminoglycoside-resistant E faecalis IE. 190”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Double-β-Lactam Regimens for E faecalis IE
What the sources say
- Not checked — no full text of the sourcecites [190] 190. Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574-579. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A large, multicenter study by Spanish and Italian investigators compared ampicillin-ceftriaxone with ampicillin-gentamicin therapy of E faecalis IE. 191”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Double-β-Lactam Regimens for E faecalis IE
What the sources say
- Not checked — no full text of the sourcecites [191] 191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treat- ing Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261-1268. doi: 10.1093/cid/cit052. 192. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Fifth, in 1 study, PVE was present in 59 (37%) and 30 (34%) of patients treated with ampicillin-ceftriaxone and ampicillingentamicin, respectively, with similar success rates.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Not checked — no full text of the sourcecites [190] 190. Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574-579. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“This study led to additional studies of experimental IE that demonstrated that the combination of ampicillin-ceftriaxone was effective therapy for gentamicin-susceptible or high-level gentamicin-resistant E faecalis experimental IE.199”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Double-β-Lactam Regimens for E faecalis IE
What the sources say
- Not checked — no full text of the sourcecites [199] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In a small number of patients, linezolid was effective therapy of vancomycin-resistant E faecium IE. 174”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Linezolid
What the sources say
- Not checked — no full text of the sourcecites [174] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The number of cases of vancomycin-resistant Enterococcus bacteremia was too small to draw significant conclusions about treatment response rates.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Daptomycin
What the sources say
- Not checked — no full text of the sourcecites [203] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Birmingham et al 202 reported cure in 17 of 22 courses of therapy (77%) for E faecium IE.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Linezolid
What the sources say
- Not checked — no full text of the sourcecites [202] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Fourth, in the larger study, the median age was 70 years in both treatment groups; however, patients in the ampicillin-ceftriaxone group were generally sicker and had more comorbid conditions (eg, chronic renal failure [P=0.004],neoplasm [P=0.015], and nosocomial acquisition of infection [P=0.006]).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Not checked — no full text of the sourcecites [191] 191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treat- ing Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261-1268. doi: 10.1093/cid/cit052. 192. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“However, linezolid treatment failures of E faecium IE also were reported.206”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Linezolid
What the sources say
- Not checked — no full text of the sourcecites [206] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Most of the reports of multidrug-resistant E faecium IE are single case reports, reports of a small number of collected cases, or cases reported in new drug trials.200”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Enterococcal Endocarditis Resistant to Penicillin, Aminoglycosides, and Vancomycin
What the sources say
- Not checked — no full text of the sourcecites [200] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“IE caused by fastidious Gram-negative bacilli of the HACEK group (HACEK indicates Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, and Kingella species) accounts for ≈5% to 10% of community-acquired NVE in patients who are not IDUs.218”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > HACEK Microorganisms
What the sources say
- Not matchedcites [218]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Second, high-level aminoglycoside-resistant E faecalis IE treated with ampicillin-ceftriaxone therapy was present in 50% of the patients in the smaller study and 33% of patients in the larger study.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Not checked — no full text of the sourcecites [190] 190. Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574-579. source
- Not checked — no full text of the sourcecites [191] 191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treat- ing Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261-1268. doi: 10.1093/cid/cit052. 192. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Salmonella species have a proclivity to infect cardiovascular structures in adults.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > HACEK Microorganisms
What the sources say
- Not checked — no full text of the sourcecites [222] 222. Reyes MP, Reyes KC. Gram-negative endocarditis. Curr Infect Dis Rep. 2008;10:267-274. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Although many serotypes have been implicated, most cases are caused by S choleraesuis, S typhimurium, and S enteritidis.222”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > HACEK Microorganisms
What the sources say
- Not checked — no full text of the sourcecites [222] 222. Reyes MP, Reyes KC. Gram-negative endocarditis. Curr Infect Dis Rep. 2008;10:267-274. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In PVE cases, the timing of infection onset can also be important in defining pathogens.235”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [235] 235. Thuny F, Fournier PE, Casalta JP, Gouriet F, Lepidi H, Riberi A, Collart F, Habib G, Raoult D. Investigation of blood culture-negative early prosthetic valve endocarditis reveals high prevalence of fungi. Heart. 2010;96:743-747. doi: 10.1136/hrt.2009.181594. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In contrast, IDU, a prominent risk factor for the development of this IE syndrome in earlier years, was recognized in only 4% of cases in the multinational survey that included cases seen between 2000 and 2005.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > HACEK Microorganisms
What the sources say
- Not checked — no full text of the sourcecites [221] 221. Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernández-Hidalgo N, Dickerman S, Bouza E, del Río A, Lejko-Zupanc T, de Oliveira Ramos A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Non-HACEK Gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829-835. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The most prevalent pathogen among these uncommon causes of culture-negative IE in this group has varied globally according to published data.236”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [236] 236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. Comprehensive diagnostic strategy for blood culture-negative endocardi- tis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131- 140. doi: 10.1086/653675. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The antimicrobial susceptibility of the organism, the dose, and the duration and nature of previous antimicrobial therapy together determine the length of time that blood cultures will remain negative.232”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [232] 232. Tunkel AR, Kaye D. Endocarditis with negative blood cultures. N Engl J Med. 1992;326:1215-1217. doi: 10.1056/NEJM199204303261809. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“It is noteworthy that healthcare exposure was associated with the development of IE caused by this group of organisms in 57% of patients.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > HACEK Microorganisms
What the sources say
- Not checked — no full text of the sourcecites [221] 221. Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernández-Hidalgo N, Dickerman S, Bouza E, del Río A, Lejko-Zupanc T, de Oliveira Ramos A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Non-HACEK Gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829-835. source
plaincorrelationaln = 49- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“True culture-negative IE can be caused by uncommon or rare pathogens that do not grow in routinely used blood culture systems.[234][235][236][237]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [234] 234. Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother. 2004;48:1921-1933. doi: 10.1128/AAC.48.6.1921-1933.2004. source
- Not checked — no full text of the sourcecites [235] 235. Thuny F, Fournier PE, Casalta JP, Gouriet F, Lepidi H, Riberi A, Collart F, Habib G, Raoult D. Investigation of blood culture-negative early prosthetic valve endocarditis reveals high prevalence of fungi. Heart. 2010;96:743-747. doi: 10.1136/hrt.2009.181594. source
- Not checked — no full text of the sourcecites [236] 236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. Comprehensive diagnostic strategy for blood culture-negative endocardi- tis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131- 140. doi: 10.1086/653675. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In 1 large multinational database 221 that included 2761 patients seen in 61 hospitals in 28 countries, only 49 cases (1.8%) were attributable to non-HACEK Gram-negative aerobic bacilli.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > HACEK Microorganisms
What the sources say
- Not checked — no full text of the sourcecites [221] 221. Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernández-Hidalgo N, Dickerman S, Bouza E, del Río A, Lejko-Zupanc T, de Oliveira Ramos A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Non-HACEK Gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829-835. source
plainn = 49- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The HACEK group is usually susceptible in vitro to fluoroquinolones.206”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > HACEK Microorganisms
What the sources say
- Not checked — no full text of the sourcecites [206] source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Although most previous studies have put the frequency of blood culture-negative IE at 5% to 10%, a European study of IE that included 820 cases indicated that ≈20% of patients with confirmed IE had all negative blood cultures.228”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [228] 228. Werner M, Andersson R, Olaison L, Hogevik H. A clinical study of cul- ture-negative endocarditis. Medicine (Baltimore). 2003;82:263-273. doi: 10.1097/01.md.0000085056.63483.d2. source
hedgedn = 820- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Administration of antimicrobial agents to IE patients before blood cultures are obtained reduces the recovery rate of bacteria by 35% to 40%.[228][229][230][231][232]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [228] 228. Werner M, Andersson R, Olaison L, Hogevik H. A clinical study of cul- ture-negative endocarditis. Medicine (Baltimore). 2003;82:263-273. doi: 10.1097/01.md.0000085056.63483.d2. source
- Not checked — no full text of the sourcecites [229] 229. Hoen B, Selton-Suty C, Lacassin F, Etienne J, Briançon S, Leport C, Canton P. Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis. 1995;20:501-506. source
- Not checked — no full text of the sourcecites [230] 230. Berbari EF, Cockerill FR 3rd, Steckelberg JM. Infective endocarditis due to unusual or fastidious microorganisms. Mayo Clin Proc. 1997;72:532- 542. doi: 10.1016/S0025-6196(11)63302-8. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The intensity of bacteremia may not be great, however, with <50 colony-forming units per 1 mL blood detected in the majority of patients in an investigation.227”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [227] 227. Werner AS, Cobbs CG, Kaye D, Hook EW. Studies on the bacteremia of bacterial endocarditis. JAMA. 1967;202:199-203. source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Noncardiac sites of metastatic infection often complicate fungal IE; this can include, for example, endophthalmitis in patients with candidal IE, which may require both systemic and intraocular antifungal therapy.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Fungi
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“The well-recognized risk factors associated with fungal IE (eg, IDU and immunocompromised state) have become less prevalent compared with the presence of a cardiovascular device, including central venous catheters, permanent pacemakers and defibrillators, and prosthetic valves.[240][241][242][243][244][245][246]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Fungi
What the sources say
- Not checked — no full text of the sourcecites [240] 240. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest. 2002;122:302-310. source
- Not checked — no full text of the sourcecites [241] 241. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endo- carditis: evidence in the world literature, 1965-1995. Clin Infect Dis. 2001;32:50-62. doi: 10.1086/317550. source
- Not checked — no full text of the sourcecites [242] 242. Nguyen MH, Nguyen ML, Yu VL, McMahon D, Keys TF, Amidi M. Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. Clin Infect Dis. 1996;22:262-267. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Fourth, no cause was defined in 35% of cases.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [236] 236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. Comprehensive diagnostic strategy for blood culture-negative endocardi- tis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131- 140. doi: 10.1086/653675. source
plainn = 759- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Results of a meta-analysis that included 879 cases of Candida IE demonstrated a marked reduction in death (prevalence odds ratio, 0.56; 95% confidence interval, 0.16-1.99)among those who underwent adjunctive valve surgery.244”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Fungi
What the sources say
- Not checked — no full text of the sourcecites [244] 244. Steinbach WJ, Perfect JR, Cabell CH, Fowler VG, Corey GR, Li JS, Zaas AK, Benjamin DK Jr. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005;51:230-247. doi: 10.1016/j. jinf.2004.10.016. source
boosteddirectn = 879- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In addition, patients who were treated with combination therapy including amphotericin B and flucytosine had reduced mortality compared with those who received antifungal monotherapy.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Fungi
What the sources say
- Not checked — no full text of the sourcecites [244] 244. Steinbach WJ, Perfect JR, Cabell CH, Fowler VG, Corey GR, Li JS, Zaas AK, Benjamin DK Jr. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005;51:230-247. doi: 10.1016/j. jinf.2004.10.016. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Third, PCR identified a pathogen in two thirds of the valves studied.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [236] 236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. Comprehensive diagnostic strategy for blood culture-negative endocardi- tis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131- 140. doi: 10.1086/653675. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In a systematic review 5 of 15 population-based IE investigations from 7 countries, after adjustment for country, the proportion of IE cases undergoing valve surgery increased 7% per decade (95% confidence interval, -0.4% to 14%; P=0.06) between 1969 and 2000.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Not checked — no full text of the sourcecites [5] 5. Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, Wilson WR, Baddour LM. A systematic review of population-based studies of infective endocarditis. Chest. 2007;132:1025-1035. doi: 10.1378/chest.06-2048. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In its secondary form, the APA syndrome has been linked to autoimmune disorders, particularly systemic lupus erythematosus, and malignancies.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [238] 238. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involve- ment (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93:1579-1587. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A correlation between longer survival and surgery may be wrongly interpreted as evidence that surgical treatment improves survival.257”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Not checked — no full text of the sourcecites [257] 257. van Walraven C, Davis D, Forster AJ, Wells GA. Time-dependent bias was common in survival analyses published in leading clini- cal journals. J Clin Epidemiol. 2004;57:672-682. doi: 10.1016/j. jclinepi.2003.12.008. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Studies 14,15,136,249,[253][254][255][256] examining the association between valve surgery and outcome in left-sided IE using propensity score analysis, however, have demonstrated conflicting results, likely because of the use of different analytical approaches.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Not checked — no full text of the sourcecites [14] 14. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Hoskin TL, Mirzoyev Z, Anavekar NS, Enders F, Moustafa S, Mookadam F, Huskins WC, Wilson WR, Baddour LM. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation. 2007;115:1721-1728. doi: 10.1161/CIRCULATIONAHA.106.658831. source
- Not checked — no full text of the sourcecites [15] 15. Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, Tattevin P, Iung B, Delahaye F, Alla F; AEPEI Study Group. The impact of valve surgery on short-and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J. 2011;32:2003-2015. doi: 10.1093/eurheartj/ehp008. source
- Not checked — no full text of the sourcecites [136] 136. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Paré C, Almirante B, Muñoz P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL, Selton-Suty C, Jones SB, Casabé J, Morris A, Corey GR, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of pros- thetic valve endocarditis. JAMA. 2007;297:1354-1361. doi: 10.1001/ jama.297.12.1354. source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, firm conclusions cannot be drawn from this trial on the effect of early surgery on mortality, given the small sample size of the study.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
plainn = 76- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In this trial, 76 patients with left-sided NVE, severe valve regurgitation without heart failure, and vegetations >10 mm were assigned to early surgery within 48 hours or to conventional treatment.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Not checked — no full text of the sourcecites [17] 17. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW. Early surgery versus conven- tional treatment for infective endocarditis. N Engl J Med. 2012;366:2466- 2473. doi: 10.1056/NEJMoa1112843. source
plainn = 76- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Until 2007, none of the published studies adjusted for survivor bias, which occurs because patients who live longer are more likely to undergo surgery than those who die early.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Not checked — no full text of the sourcecites [257] 257. van Walraven C, Davis D, Forster AJ, Wells GA. Time-dependent bias was common in survival analyses published in leading clini- cal journals. J Clin Epidemiol. 2004;57:672-682. doi: 10.1016/j. jclinepi.2003.12.008. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The risk of intracranial hemorrhage is dependent on several factors, including extent and size of infarction, whether it is ischemic or hemorrhagic, and the exact timing of surgery.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“No randomized trials have addressed this conundrum.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“There is a paucity of evidence available to define the optimal timing of valve surgery.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Indications for Surgery
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Moreover, many patients had signs of embolization (a Class IIa indication for surgery) before randomization.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Not checked — no full text of the sourcecites [17] 17. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW. Early surgery versus conven- tional treatment for infective endocarditis. N Engl J Med. 2012;366:2466- 2473. doi: 10.1056/NEJMoa1112843. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Although outcomes are better for patients with right-sided IE compared with patients with left-sided infection, surgical intervention is occasionally considered in the former group.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Early Valve Surgery in
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Although valve replacement surgery has served as an important option in the management of individual IE cases, only 1 small, randomized trial 17 has been performed to date to examine the role of valve surgery in the management of IE.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Not checked — no full text of the sourcecites [17] 17. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW. Early surgery versus conven- tional treatment for infective endocarditis. N Engl J Med. 2012;366:2466- 2473. doi: 10.1056/NEJMoa1112843. source
plainn = 76- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Another prospective TEE study, however, found no clear correlation of vegetation size with embolization.59”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [59] 59. Erbel R, Rohmann S, Drexler M, Mohr-Kahaly S, Gerharz CD, Iversen S, Oelert H, Meyer J. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach: a pro- spective study. Eur Heart J. 1988;9:43-53. source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Nevertheless, the same investigators later reported the results of a new prospective study of 118 patients who underwent TEE and found that, on multivariable analysis, risk factors associated with embolic risk included vegetation size >10 mm and mitral valve involvement.56”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [56] 56. Rohmann S, Erbel R, Görge G, Makowski T, Mohr-Kahaly S, Nixdorff U, Drexler M, Meyer J. Clinical relevance of vegetation localization by transoesophageal echocardiography in infective endocarditis. Eur Heart J. 1992;13:446-452. doi: http://dx.doi.org. source
plaincorrelationaln = 118- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“After adjustment for other risk factors such as age, paravalvular abscess, and heart failure, the risk of hospital mortality remained nonsignificantly higher in the early surgery group (odds ratio, 2.308; 95% confidence interval, 0.942-5.652).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Not checked — no full text of the sourcecites [273] source
plainn = 198- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“De Castro and colleagues 276 compared TTE with multiplane TEE and found that neither technique was helpful in defining embolic risk in patients with vegetations.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [276] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In a study from 1991, the embolic rate dropped from 13 to <1.2 embolic events per 1000 patient-days during that time.58”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [58] 58. Steckelberg JM, Murphy JG, Ballard D, Bailey K, Tajik AJ, Taliercio CP, Giuliani ER, Wilson WR. Emboli in infective endocarditis: the prognos- tic value of echocardiography. Ann Intern Med. 1991;114:635-640. Doi: 10.7326/0003-4819-114-8-635. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Differences in 1-year mortality were less pronounced, with an adjusted hazard ratio of 1.138 (95% confidence interval, 0.802-1.650).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Not checked — no full text of the sourcecites [273] source
plainn = 198- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In a survey that included the International Collaboration on Endocarditis cohort, Dickerman and colleagues 280 focused on the incidence of stroke in a multicenter IE population and demonstrated that acute stroke rates fell significantly after initiation of antibiotic therapy regardless of valve involved or pathogen identified.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [280] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In-hospital mortality in the early surgery group was comparable to that of the medically treated patients.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Not checked — no full text of the sourcecites [273] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Moreover, only 3.1% of the cohort suffered stroke after the first week of antimicrobial therapy; this finding has led to the opinion that stroke prevention as a sole indication for valve surgery after 1 week of appropriate antibiotic therapy is not warranted.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [280] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because of the observed decreases in embolic risk during the first 2 weeks of antibiotic therapy, the benefit of surgery in avoiding catastrophic embolic events is greatest early in the treatment course of IE.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“On the basis of TEE findings in 384 consecutive adult patients with definite IE, vegetation length >15 mm was a predictor of 1-year mortality (adjusted relative risk, 1.8; 95% confidence interval, 1.10-2.82;P=0.02) in multivariable analysis.281”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [281] source
plaincorrelationaln = 384 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In aortic NVE, this generally occurs through the weakest portion of the annulus, which is near the membranous septum and atrioventricular node.299”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Not checked — no full text of the sourcecites [299] 299. Becher H, Hanrath P, Bleifeld W, Bleese N. Correlation of echocardio- graphic and surgical findings in acute bacterial endocarditis. Eur Heart J. 1984;5(suppl C):67-70. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“An increase in vegetation size over 4 to 8 weeks of therapy as documented by TEE appears to predict embolic events.282”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [282] source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The benefit of therapeutic anticoagulation has never been demonstrated convincingly in patients with NVE.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Anticoagulation
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“As noted above, the highest embolic risk (37%) has been seen in the subset of patients with mitral vegetations attached to the anterior rather than the posterior mitral leaflet.59,63”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [59] 59. Erbel R, Rohmann S, Drexler M, Mohr-Kahaly S, Gerharz CD, Iversen S, Oelert H, Meyer J. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach: a pro- spective study. Eur Heart J. 1988;9:43-53. source
- Not checked — no full text of the sourcecites [63] 63. Konstadt SN, Louie EK, Shore-Lesserson L, Black S, Scanlon P. The effects of loading changes on intraoperative Doppler assessment of mitral regurgitation. J Cardiothorac Vasc Anesth. 1994;8:19-23. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Moreover, the study with the largest number of patients (n=176) that assessed the value of TEE and included silent embolism detected by CT scanning demonstrated that the risk of embolic events was highly related to vegetation size and mobility but not to other known risk factors associated with embolism in IE. 283”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [283] source
boostedcorrelationaln = 176- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Perivalvular cavities form when annular infections break through and spread into contiguous tissue.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Other independent predictors of death by logistic regression modeling among 267 consecutive patients with definite or possible IE by modified Duke criteria were diabetes mellitus, S aureus infection, and Acute Physiology And Chronic Health Evaluation (APACHE) II score.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [285] source
plaincorrelationaln = 267- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Aspirin levels, a critical correlate of antimicrobial efficacy in an animal model, were not monitored in this study.289”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Anticoagulation
What the sources say
- Not checked — no full text of the sourcecites [289] 289. Kupferwasser LI, Yeaman MR, Shapiro SM, Nast CC, Sullam PM, Filler SG, Bayer AS. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation. 1999;99:2791-2797. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This suggests that the mechanical effects of broad and abrupt leaflet excursion, occurring twice per heartbeat, may contribute to the propensity of a vegetation in this location to fragment and embolize.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In 1 analysis, an embolic event was 1 of 4 early predictors of in-hospital death caused by IE. 285”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [285] source
plaincorrelationaln = 267- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Anticoagulation in IE patients is controversial, particularly in mechanical valve IE. 286”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Anticoagulation
What the sources say
- Not checked — no full text of the sourcecites [286] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Overall, these data are compatible with previous observations that indicate that, in general, mitral vegetations of any size are associated with a higher risk of embolization (25%) than aortic vegetations (10%).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“However, all of the series that included >100 patients who underwent TEE showed a positive relationship between embolic events and vegetation size.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In another study, the effect of vegetation size on embolic potential was dependent on the infecting organism, with large vegetations independently predicting embolic events only in the setting of streptococcal IE. 60”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [60] 60. Rohmann S, Erbel R, Darius H, Görge G, Makowski T, Zotz R, Mohr- Kahaly S, Nixdorff U, Drexler M, Meyer J. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr. 1991;4:465-474. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The mortality rate was 41% in a series 304 of patients with aorto-cavitary fistulization despite surgical intervention in 87%.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Not checked — no full text of the sourcecites [304] source
plainn = 304- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In some cases, progressive periannular infection totally disrupts the ventricular-aortic continuity or the mitral-aortic trigone.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The overall mortality rate among IE patients with ICMAs is 60%.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Intracranial MAs
What the sources say
- Not checked — no full text of the sourcecites [315] source
- Not matchedcites [316]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Among patients with unruptured ICMAs, the mortality rate is 30%;”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Intracranial MAs
What the sources say
- Not checked — no full text of the sourcecites [315] source
- Not matchedcites [316]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Drainage of abscess cavities, excision of necrotic tissue, and closure of fistulous tracts often accompany valve replacement or repair surgery.309”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Not matchedcites [309]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Periannular infection is of even greater concern with PVE, occurring in 56% to 100% of patients.298,302”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Not checked — no full text of the sourcecites [298] 298. Blumberg EA, Karalis DA, Chandrasekaran K, Wahl JM, Vilaro J, Covalesky VA, Mintz GS. Endocarditis-associated paravalvular abscesses: do clinical parameters predict the presence of abscess? Chest. 1995;107:898-903. source
- Not checked — no full text of the sourcecites [302] 302. Carpenter JL. Perivalvular extension of infection in patients with infec- tious endocarditis. Rev Infect Dis. 1991;13:127-138. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Under the influence of systemic intravascular pressures, abscesses may progress to fistulous tracts that create intracardiac or pericardial shunts.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Persistent bacteremia or fever, recurrent emboli, heart block, heart failure, or a new pathological murmur in a patient with IE on appropriate antibiotics may suggest extension.303”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Not checked — no full text of the sourcecites [303] 303. Anguera I, Miro JM, Vilacosta I, Almirante B, Anguita M, Muñoz P, Roman JA, de Alarcon A, Ripoll T, Navas E, Gonzalez-Juanatey C, Cabell CH, Sarria C, Garcia-Bolao I, Fariñas MC, Leta R, Rufi G, Miralles F, Pare C, Evangelista A, Fowler VG Jr, Mestres CA, de Lazzari E, Guma JR; Aorto-cavitary Fistula in Endocarditis Working Group. Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J. 2005;26:288-297. doi: 10.1093/eurheartj/ehi034. 304. source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Multiple ICMAs occur in 20% of cases 319”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Intracranial MAs
What the sources say
- Not checked — no full text of the sourcecites [319] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“mortality rates are similar for multiple and single distal ICMAs.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Intracranial MAs
What the sources say
- Not checked — no full text of the sourcecites [319] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Symptomatic cerebral emboli frequently but not invariably precede the finding of an ICMA.315”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Intracranial MAs
What the sources say
- Not checked — no full text of the sourcecites [315] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“in patients with ruptured ICMAs, the mortality rate approaches 80%.315,316”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Intracranial MAs
What the sources say
- Not checked — no full text of the sourcecites [315] source
- Not matchedcites [316]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The mortality rate for patients with proximal ICMAs is >50%.321”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Intracranial MAs
What the sources say
- Not matchedcites [321]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“In other patients, there are no clinically recognized premonitory findings before sudden subarachnoid or intraventricular hemorrhage.315”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Intracranial MAs
What the sources say
- Not checked — no full text of the sourcecites [315] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The reported occurrence of ICMAs in 1.2% to 5% of cases [316][317][318][319][320]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Intracranial MAs
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“is probably underestimated because some ICMAs remain asymptomatic and resolve with antimicrobial therapy.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Intracranial MAs
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“and ICMAs are seen with increased frequency among IDUs with IE. 318”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Intracranial MAs
What the sources say
- Not checked — no full text of the sourcecites [318] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 88
- Probably not a substantial claim. 18
- The quote only partly states this claim. 2
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“However, these initial studies included a limited number of patients, and risk adjustments were not performed.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Supportedcites [265] 265. Maruyama M, Kuriyama Y, Sawada T, Yamaguchi T, Fujita T, Omae T. Brain damage after open heart surgery in patients with acute cardioem- bolic stroke. Stroke. 1989;20:1305-1310. source
The Abstract (page not supplied) reports a series of 14 patients, supporting the limited-sample characterization. Its outcome comparisons and Table 1 present descriptive and unadjusted results; the paper reports no risk-adjusted analysis. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [266] 266. Gillinov AM, Shah RV, Curtis WE, Stuart RS, Cameron DE, Baumgartner WA, Greene PS. Valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg. 1996;61:1125-1129. source
- Disputedcites [267] 267. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cere- bral complications: multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995;110:1745-1755. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says earlier studies had limited numbers of cases but describes this study’s 181 analyzed patients as sufficient for examining surgical timing. Patients and methods (page unavailable) also reports stepwise regression analysis of risk factors, contrary to the unqualified claim that risk adjustments were not performed. (LLM, conf=0.83)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Extension of IE beyond the valve annulus predicts a higher mortality rate, more frequent development of heart failure, and more frequent need for cardiac surgery.284,297,298”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Disputedcites [284] sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) says early echocardiographic findings were not predictive of in-hospital death. Table 1 (page unavailable) reports no statistically significant association between abscess and death (OR 1.52; P=0.525), contrary to the claimed mortality prediction. The Discussion identifies perivalvular extension as an indication for surgery, but does not show that it predicts more frequent heart failure or surgery. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [297] 297. Middlemost S, Wisenbaugh T, Meyerowitz C, Teeger S, Essop R, Skoularigis J, Cronje S, Sareli P. A case for early surgery in native left- sided endocarditis complicated by heart failure: results in 203 patients. J Am Coll Cardiol. 1991;18:663-667. sourceExperimental — accuracy not yet measured
The Methods define extensive infection as spread to the annulus or adjacent tissues, and the Results report five postoperative deaths among patients with extensive aortic infection versus two with limited aortic infection. But this was a surgical series of patients with heart failure; it does not establish that extension predicts more frequent heart failure or a greater need for surgery, and the authors conclude that extensive infection is not necessarily associated with high surgical risk when surgery is early (Discussion). No page number is available in our copy. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [298] 298. Blumberg EA, Karalis DA, Chandrasekaran K, Wahl JM, Vilaro J, Covalesky VA, Mintz GS. Endocarditis-associated paravalvular abscesses: do clinical parameters predict the presence of abscess? Chest. 1995;107:898-903. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“of 59 consecutive patients with S aureus IE, 45.8% had nosocomial infections, and 50.8% had a removable focus of infection.39”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Partly supportedcites [39] 39. Fowler VG Jr, Sanders LL, Kong LK, McClelland RS, Gottlieb GS, Li J, Ryan T, Sexton DJ, Roussakis G, Harrell LJ, Corey GR. Infective endocar- ditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis. 1999;28:106-114. doi: 10.1086/515076. sourceExperimental — accuracy not yet measured
Table 2 reports 27 hospital-acquired cases among 59 patients (45.8%). The Sources of Infection section reports that an intravascular device was the presumed source in 30 patients (50.8%), but it does not establish that all 30 had a removable focus of infection. (LLM, conf=0.88)
plainn = 59- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In the predefined subgroup of those with MRSA bacteremia, daptomycin demonstrated a 44.4% success rate compared with 31.8% for standard therapy; this difference was not statistically significant (absolute difference, 12.6%, 95% confidence interval, -7.4 to 32.6; P=0.28).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Right-Sided IE in IDUs
What the sources say
- Supportedcites [13] 13. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-665. doi: 10.1056/NEJMoa053783. source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Patterns of diffusion differ by class of antibiotic, which may have implications for therapeutic outcomes in patients being treated for IE.[98][99][100]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Drug Penetration
What the sources say
- Partly supportedcites [98] 98. Fantin B, Leclercq R, Ottaviani M, Vallois JM, Maziere B, Duval J, Pocidalo JJ, Carbon C. In vivo activities and penetration of the two com- ponents of the streptogramin RP 59500 in cardiac vegetations of experi- mental endocarditis. Antimicrob Agents Chemother. 1994;38:432-437. sourceExperimental — accuracy not yet measured
The Discussion describes different diffusion patterns for RPI and RPII in rabbit cardiac vegetations, and the Results report differences in their penetration. This supports the diffusion point, but the study compares two components of one streptogramin combination, not antibiotic classes generally, and does not establish therapeutic implications in patients with infective endocarditis. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [99] 99. Mertes PM, Jehl F, Burtin P, Dopff C, Pinelli G, Villemot JP, Monteil H, Dureux JB. Penetration of ofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans. Antimicrob Agents Chemother. 1992;36:2493-2496. 100. Nicolau DP, Freeman CD, Nightingale CH, Coe CJ, Quintiliani R. Minocycline versus vancomycin for treatment of experimental endocar- ditis caused by oxacillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1994;38:1515-1518. 101. Rybak MJ. Pharmacodynamics: relation to antimicrobial resistance. Am J Med. 2006;119(suppl 1):S37-S44. doi: source
- Not checked — no full text of the sourcecites [100] 100. Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, Dalovisio JR, Levine DP. Therapeutic monitoring of vanco- mycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists [published correction appears in Am J Health Syst Pharm. 2009;66:887]. Am J Health Syst Pharm. 2009;66:82-98. doi: 10.2146/ajhp080434. 113. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Of note, in a post hoc analysis of this landmark clinical trial, 149 the addition of even such low-dose, short-course gentamicin in 1 arm of the study was significantly associated with renal toxicity, which occurred early and often, and the clinical association between gentamicin dose and duration was minimal.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Right-Sided IE in IDUs
What the sources say
- Supportedcites [149] 149. Cosgrove SE, Vigliani GA, Fowler VG Jr, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW. Initial low- dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis. 2009;48:713-721. doi: 10.1086/597031. source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Moreover, use of rifampin as adjunct therapy for S aureus NVE has been associated with higher rates of adverse events (primarily hepatotoxicity) and a significantly lower survival rate.162”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Additional or Adjunctive Therapies
What the sources say
- Supportedcites [162] 162. Riedel DJ, Weekes E, Forrest GN. Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus. Antimicrob Agents Chemother. 2008;52:2463- 2467. doi: 10.1128/AAC.00300-08. source
The Results (Table 3) report more elevated hepatic transaminases in rifampin recipients than controls (9 versus 1; P = 0.014), with elevations confined to patients with hepatitis C. The Abstract reports significantly lower survival among rifampin recipients (79% versus 95%; P = 0.048). The claim describes an association, consistent with this retrospective study. (LLM, conf=0.92)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The 2005 AHA document 12 recommended streptomycin for patients with gentamicin-resistant strains of enterococci.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > E faecalis IE Susceptible to Penicillin, Resistant to Aminoglycosides, or Gentamicin Resistant and Streptomycin Susceptible
What the sources say
- Partly supportedcites [12] 12. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA. Infective endocarditis: diagno- sis, antimicrobial therapy, and management of complications: a state- ment for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American sourceExperimental — accuracy not yet measured
The section on enterococci resistant to gentamicin recommends a streptomycin regimen, but specifically for strains susceptible to streptomycin, penicillin, and vancomycin. It says only some gentamicin-resistant strains remain susceptible to streptomycin, so the claim is too broad without that qualification. No page number is available in our copy. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The median duration of aminoglycoside therapy was 15 days, and the microbiological cure and survival rates were similar to those for patients who received longer courses of gentamicin therapy.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Short-Course (≈2-Week) Gentamicin Therapy
What the sources say
- Partly supportedcites [189] 189. Olaison L, Schadewitz K; Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis. Enterococcal endo- carditis in Sweden, 1995-1999: can shorter therapy with aminogly- cosides be used? Clin Infect Dis. 2002;34:159-166. doi: 10.1086/ 338233. sourceExperimental — accuracy not yet measured
The Results (p. 3) report a median of 15 days of aminoglycoside therapy in episodes with clinical cure. The Discussion (pp. 6–7) describes good outcomes with shortened treatment, but our copy does not report similar microbiological-cure and survival rates compared with a longer-course gentamicin group; it discusses several aminoglycosides. (LLM, conf=0.87)
plainn = 78- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In 1 survey, 60% of isolates did not grow adequately in control wells, and no valid in vitro susceptibility results were available.219”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > HACEK Microorganisms
What the sources say
- Supportedcites [219] source
The Abstract reports that 104 of 174 HACEK isolates (59.8%) failed to grow adequately in the control well and therefore could not provide valid susceptibility results. This directly supports the citing sentence’s rounded figure of 60%. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, β-lactamaseproducing strains of HACEK are appearing with increased frequency; rarely, resistance to ampicillin can occur in β-lactamase-negative strains.219”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > HACEK Microorganisms
What the sources say
- Partly supportedcites [219] sourceExperimental — accuracy not yet measured
The discussion following Table 1 reports penicillin/ampicillin resistance in one Eikenella corrodens isolate without β-lactamase production, supporting the rare-exception claim. The paper also identifies two β-lactamase-positive isolates, but it does not establish that β-lactamase-producing HACEK strains are appearing with increased frequency. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Moreover, some of the laboratory-based diagnostic techniques to define fastidious or unusual pathogens are not available in most clinical laboratories and require considerable time for completion of testing if specimens are sent to a referral laboratory.233”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Supportedcites [233] 233. Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr, Bourbeau P, Carroll KC, Kehl SC, Dunne WM, Robinson-Dunn B, Schwartzman JD, Chapin KC, Snyder JW, Forbes BA, Patel R, Rosenblatt JE, Pritt BS. A guide to utilization of the microbiology labo- ratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013;57:e22-e121. doi: 10.1093/cid/cit278. source
In IX. Bone and Joint Infections, the paper says molecular tests for some less common agents often must be sent to a reference laboratory, resulting in longer turnaround times. XV. Blood and Tissue Parasite Infections likewise says certain molecular assays are restricted to reference laboratories and results may arrive later than is desirable for patient care. The claim appropriately says “some” techniques, rather than implying this applies to all fastidious pathogens. (LLM, conf=0.90)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“When adjusted for survivor bias, analyses have shown either a statistical loss of benefit of early surgery or findings indicating that the surgical intervention may actually result in harm.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Not checked — no full text of the sourcecites [15] 15. Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, Tattevin P, Iung B, Delahaye F, Alla F; AEPEI Study Group. The impact of valve surgery on short-and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J. 2011;32:2003-2015. doi: 10.1093/eurheartj/ehp008. source
- Supportedcites [16] 16. Sy RW, Bannon PG, Bayfield MS, Brown C, Kritharides L. Survivor treat- ment selection bias and outcomes research: a case study of surgery in infective endocarditis. Circ Cardiovasc Qual Outcomes. 2009;2:469-474. doi: 10.1161/CIRCOUTCOMES.109.857938. source
The Effect of Surgery on Mortality section reports that the apparent mortality benefit was no longer statistically significant after time-dependent analysis to account for survivor bias. The Discussion also reports a study in which surgery was associated with potential harm. These findings concern surgery for infective endocarditis. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [258] 258. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Montori VM, Hoskin TL, Enders F, Huskins WC, Mookadam F, Wilson WR, Zimmerman V, Baddour LM. Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias. J Clin Epidemiol. 2010;63:130-135. doi: 10.1016/j. jclinepi.2008.06.022. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Emboli can occur before diagnosis, during therapy, or after therapy is completed, although most emboli occur within the first 2 to 4 weeks of antimicrobial therapy.58,278”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [58] 58. Steckelberg JM, Murphy JG, Ballard D, Bailey K, Tajik AJ, Taliercio CP, Giuliani ER, Wilson WR. Emboli in infective endocarditis: the prognos- tic value of echocardiography. Ann Intern Med. 1991;114:635-640. Doi: 10.7326/0003-4819-114-8-635. source
- Supportedcites [278] source
The introductory passage says emboli can occur before diagnosis, during treatment, or after therapy is completed. The Results report that 65% of embolic events after antibiotics began occurred within the first two weeks, which supports the claim’s broader ‘first 2 to 4 weeks’ window. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Ruttmann et al 270 analyzed 65 patients who underwent cardiac surgery after cardioembolic (embolic) stroke (median time, 4 days; range, 0-38 days).Surgery in this time frame was not associated with worse patient outcomes.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Supportedcites [270] 270. Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, Laufer G, Müller LC. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094-2099. doi: 10.1161/01. STR.0000229894.28591.3f. source
The Preoperative Neurological Findings section reports 65 patients with septic cerebral embolism and a median of 4 days from stroke to surgery (range 0–38 days). The Postoperative Neurological Recovery section reports that surgery within 4 days, compared with later surgery, was not associated with a higher perioperative neurological complication rate or worse neurological recovery. (LLM, conf=0.90)
plainn = 65- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Vilacosta et al 278 confirmed the reduced frequency of embolization after 2 weeks of therapy.Moreover, the latter study reemphasized the increased risk of embolization with increasing vegetation size during therapy, mitral valve involvement, and staphylococcal pathogenesis.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Partly supportedcites [278] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The largest early series of operated patients with cerebral complications included 181 patients.267 Hospital mortality rates as a function of the interval between evidence of cerebral infarction to cardiac surgery were 66.3% when surgery was performed within 24 hours of stroke and gradually decreased every week to 7.0% with surgery >4 weeks after stroke.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Partly supportedcites [267] 267. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cere- bral complications: multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995;110:1745-1755. sourceExperimental — accuracy not yet measured
The Conclusion reports 181 patients with infective endocarditis and cerebral complications. The ‘Influence of cardiac surgery on preoperative cerebral infarction’ section gives the claimed 66.3% mortality within 24 hours and 7.0% after more than four weeks, but mortality did not decrease every week: it rose from 10.0% at 15–21 days to 26.3% at 22–28 days. The supplied passages have no page numbers. (LLM, conf=0.91)
plaincorrelationaln = 181- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Latency between the neurological event and cardiac surgery was not a significant factor with respect to the perioperative neurological complication rate or the postoperative neurological recovery rate.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Supportedcites [270] 270. Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, Laufer G, Müller LC. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094-2099. doi: 10.1161/01. STR.0000229894.28591.3f. source
The Postoperative Neurological Recovery section directly reports that surgery within four days of stroke versus later showed no significant difference in perioperative neurological complications (P=0.32) or postoperative neurological recovery (P=0.68). This supports the claim for the timing comparison studied. (LLM, conf=0.95)
plainn = 65- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Retrospective, observational studies 290-296 have examined the impact, if any, of long-term antiplatelet therapy before the onset of IE on infection-related outcomes.Findings from these investigations have been mixed in terms of IE-related outcomes.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Anticoagulation
What the sources say
- Not checked — no full text of the sourcecites [290] 290. Anavekar NS, Tleyjeh IM, Anavekar NS, Mirzoyev Z, Steckelberg JM, Haddad C, Khandaker MH, Wilson WR, Chandrasekaran K, Baddour LM. Impact of prior antiplatelet therapy on risk of embolism in infective endo- carditis [published correction appears in Clin Infect Dis. 2007;44:1398]. Clin Infect Dis. 2007;44:1180-1186. doi: 10.1086/513197. source
- Not checked — no full text of the sourcecites [291] 291. Chan KL, Tam J, Dumesnil JG, Cujec B, Sanfilippo AJ, Jue J, Turek M, Robinson T, Williams K. Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis. 2008;46:37-41. doi: 10.1086/524021. source
- Not checked — no full text of the sourcecites [292] 292. Eisen DP, Corey GR, McBryde ES, Fowler VG Jr, Miro JM, Cabell CH, Street AC, Paiva MG, Ionac A, Tan RS, Tribouilloy C, Pachirat O, Jones SB, Chipigina N, Naber C, Pan A, Ravasio V, Gattringer R, Chu VH, Bayer AS; ICE Investigators. Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiv- ing acetyl-salicylic acid. J Infect. 2009;58:332-338. doi: 10.1016/j. jinf.2009.03.006. source
- Not checked — no full text of the sourcecites [293] 293. Pepin J, Tremblay V, Bechard D, Rodier F, Walker C, Dufresne D, Lafontaine A, Li N, Lacroix C, Lanthier L. Chronic antiplatelet therapy and mortality among patients with infective endocarditis. Clin Microbiol Infect. 2009;15:193-199. doi: 10.1111/j.1469-0691. 2008.02665.x. source
- Not checked — no full text of the sourcecites [294] 294. Snygg-Martin U, Rasmussen RV, Hassager C, Bruun NE, Andersson R, Olaison L. The relationship between cerebrovascular complica- tions and previously established use of antiplatelet therapy in left- sided infective endocarditis. Scand J Infect Dis. 2011;43:899-904. doi: 10.3109/00365548.2011.603742. source
- Supportedcites [295] 295. Anavekar NS, Schultz JC, De Sa DD, Thomas JM, Lahr BD, Tleyjeh IM, Steckelberg JM, Wilson WR, Baddour LM. Modifiers of symptomatic embolic risk in infective endocarditis [published correction appears in Mayo Clin Proc. 2012;87:309]. Mayo Clin Proc. 2011;86:1068-1074. doi: 10.4065/mcp.2011.0111. source
The Patients and Methods section describes a retrospective cohort comparing patients who received antiplatelet therapy before infection with those who did not. The Discussion contrasts an earlier study’s reduction in symptomatic emboli with this study’s finding that the association was not statistically significant after adjustment. These passages support the characterization of mixed findings for IE-related outcomes; page numbers were not supplied. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [296] 296. Omari B, Shapiro S, Ginzton L, Robertson JM, Ward J, Nelson RJ, Bayer AS. Predictive risk factors for periannular extension of native valve endocarditis: clinical and echocardiographic analyses. Chest. 1989;96:1273-1279. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
Every source the paper cites for this claim was checked and supports it.
In the paper
“No significant benefit was observed in aspirin-treated patients in terms of vegetation resolution and embolic events.Moreover, there was a trend toward more bleeding episodes in the aspirin-treated patients.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Anticoagulation
What the sources say
- Supportedcites [288] 288. Chan KL, Dumesnil JG, Cujec B, Sanfilippo AJ, Jue J, Turek MA, Robinson TI, Moher D; Investigators of the Multicenter Aspirin Study in Infective Endocarditis. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol. 2003;42:775-780. source
The Results report no significant difference in embolic events and a higher overall bleeding rate in the aspirin group (p = 0.075). The “Effect on vegetation” section reports similar reductions in vegetation size in the aspirin and placebo groups; the Discussion says aspirin had no significant effect on vegetation size or number. (LLM, conf=0.94)
plainn = 115- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“TEE dramatically improves the sensitivity for defining periannular extension of IE (76% to 100%) while retaining excellent specificity (95%) and positive and negative predictive values (87% and 89%, respectively).54,307”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Partly supportedcites [54] 54. Daniel WG, Mügge A, Martin RP, Lindert O, Hausmann D, Nonnast- Daniel B, Laas J, Lichtlen PR. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med. 1991;324:795-800. doi: 10.1056/NEJM199103213241203. sourceExperimental — accuracy not yet measured
The Transesophageal Echocardiography section (p. 2) reports that TEE detected more endocarditis-associated abscesses than transthoracic echocardiography, with specificity of 94.6%—approximately the claimed 95%. It reports TEE sensitivity of 87%, positive predictive value of 90.9%, and negative predictive value of 92.1%, not the claimed sensitivity range of 76% to 100% and predictive values of 87% and 89%. (LLM, conf=0.90)
- Could not verifycites [307] sourceExperimental — accuracy not yet measured
The case report describes echocardiographic identification of a mitral anular abscess (Course and echocardiographic findings; Discussion, pp. 953–955). Our copy does not assess TEE against another method or report the claimed sensitivity, specificity, or predictive values; searches for those terms and figures found no supporting passage. (LLM, conf=0.78)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Under these conditions, human aortic homografts, when available, can be used to replace the damaged aortic valve and to reconstruct the damaged aorta.310,311”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Supportedcites [310] source
The operative-technique passage describes removing the infected prosthetic valve and necrotic tissue, inserting a homograft aortic root, and sewing it to the remaining aorta. The Discussion says this approach is particularly useful when infection has destroyed the valve ring; it also notes that homograft tissue may be in limited supply. Together, these passages support the stated use under the specified conditions. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [311] source
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
In the paper
“Fournier et al 40 studied 20 pathologically confirmed cases of Q fever IE.When the original Duke criteria were used, 4 of the 20 patients were classified as having possible IE.When Q fever serological results and a single blood culture positive for C burnetii were considered to be a major criterion, however, each of these 4 cases was reclassified from possible IE to definite IE.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Not checked — no full text of the sourcecites [40] 40. Fournier PE, Casalta JP, Habib G, Messana T, Raoult D. Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. Am J Med. 1996;100:629-633. source
plaindirectn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In a reanalysis of patients in the Duke University database (containing records collected prospectively on >800 cases of definite and possible IE since 1984), this echocardiographic criterion was used in only 5% of cases and was never used in the final analysis of any patient who underwent transesophageal echocardiography (TEE).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
plainn = 800- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Cases with limited manifestations of IE may occur early during IE, particularly among patients who are injection drug users (IDUs), in whom IE is often the result of acute S aureus infection of right-sided heart valves.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Diagnosis
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Although the overall IE incidence has remained stable, 1,2,[5][6][7][8][9]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Abstract
What the sources say
- Not matchedcites 1,2,[5][6][7][8][9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The major limitations of the erythrocyte sedimentation rate and C-reactive protein are that they are nonspecific and particularly challenging to interpret in patients with comorbid conditions.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Right-sided IE, however, can cause septic pulmonary emboli.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Diagnosis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Characteristics of IE patients have also shifted toward an increased mean patient age, a higher proportion of prosthetic valves and other cardiac devices, and a decreasing proportion of rheumatic heart disease.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Abstract
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The studies [27][28][29][30][31][32][33][34][35][36][37][38] confirmed the high sensitivity and specificity of the Duke criteria and the diagnostic utility of echocardiography in identifying clinically definite cases.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Diagnosis
What the sources say
- Not matchedcites [27][28][29][30][31][32][33][34][35][36][37][38]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaincorrelationaln = 1,700- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Not matched
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Some patients will have significant valvular dysfunction at the end of otherwise successful antimicrobial treatment that will require eventual valvular surgery.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Echocardiography at the Completion of Therapy
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“All patients who have experienced an episode of IE remain at increased risk for recurrent infection indefinitely.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Echocardiography at the Completion of Therapy
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
In the paper
“Both β-lactam therapy alone and combination therapy with nafcillin and an aminoglycoside for only 2 weeks have been effective in patients with uncomplicated right-sided IE caused by S aureus 91 ; monotherapy with a β-lactam would be selected for use in cases of uncomplicated IE. 92”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Duration of Antimicrobial Therapy
What the sources say
- Not checked — no full text of the sourcecites [91] 91. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med. 1988;109:619-624. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In a prospective study of 25 IE cases, 18 F-fluorodeoxyglucose positron emission tomography/ CT was useful in identifying peripheral embolization in 11 patients and in detecting IE extracardiac manifestations in 7 patients who did not demonstrate any clinical manifestations of IE. 70”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > 3D Echocardiography and Other Imaging Modalities
What the sources say
- Not checked — no full text of the sourcecites [70] 70. Van Riet J, Hill EE, Gheysens O, Dymarkowski S, Herregods MC, Herijgers P, Peetermans WE, Mortelmans L. (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging. 2010;37:1189-1197. doi: 10.1007/s00259-010-1380-x. source
plaindirectn = 25- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Criteria changes that add sensitivity often do so at the expense of specificity and vice versa.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“In the setting of a prosthetic valve, transthoracic images are greatly hampered by the structural components of the prosthesis and are inadequate for assessment of the perivalvular area where those infections often start.48”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Echocardiography
What the sources say
- Not checked — no full text of the sourcecites [48] 48. Daniel WG, Mügge A, Grote J, Hausmann D, Nikutta P, Laas J, Lichtlen PR, Martin RP. Comparison of transthoracic and transesophageal echocar- diography for detection of abnormalities of prosthetic and bioprosthetic valves in the mitral and aortic positions. Am J Cardiol. 1993;71:210-215. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“An interval increase in vegetation size on serial echocardiography despite the administration of appropriate antibiotic therapy has serious implications and has been associated with an increased risk of complications and the need for surgery.60”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Repeat Echocardiography
What the sources say
- Not checked — no full text of the sourcecites [60] 60. Rohmann S, Erbel R, Darius H, Görge G, Makowski T, Zotz R, Mohr- Kahaly S, Nixdorff U, Drexler M, Meyer J. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr. 1991;4:465-474. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Several echocardiographic features identify patients at high risk for a complicated course or with a need for surgery (Table 5).These features include large (>10 mm in diameter) vegetations, severe valvular insufficiency, abscess cavities or pseudoaneurysms, valvular perforation or dehiscence, and evidence of decompensated heart failure.21”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Echocardiography
What the sources say
- Not checked — no full text of the sourcecites [21] 21. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, Okum EJ, Wilson WR, Beerman LB, Bolger AF, Estes NA 3rd, Gewitz M, Newburger JW, Schron EB, Taubert KA; on behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; and Interdisciplinary Council on Quality of Care. Update on cardiovascu- lar implantable electronic device infections and their management: source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“the lower temporal and lateral resolution with 3D echocardiography compared with 2-dimensional echocardiography leads to an overestimation of vegetation size and technically challenging visualization of fast-moving structures.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > 3D Echocardiography and Other Imaging Modalities
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“the role of cerebral MRI and magnetic resonance angiography in the diagnosis and management of IE has been better defined in several studies.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“several risk stratification models for quantifying morbidity and mortality in IE patients overall and particularly in those undergoing valve surgeries have been developed and validated.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Six common but less specific findings of IE were included as minor criteria in the original Duke schema (Tables 2 and 3).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Diagnosis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“diagnostic innovations have emerged through new imaging techniques such as 3-dimensional (3D) echocardiography,”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“The Duke criteria gave diagnostic weight to bacteremia with staphylococci or enterococci only, on the basis of the location of acquisition and without an apparent primary focus; these types of bacteremia have the highest risk of being associated with IE. 23,25,26”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Diagnosis
What the sources say
- Not checked — no full text of the sourcecites [23] 23. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infec- tive endocarditis: utilization of specific echocardiographic findings: Duke Endocarditis Service. Am J Med. 1994;96:200-209. source
- Not checked — no full text of the sourcecites [25] 25. Bayer AS, Lam K, Ginzton L, Norman DC, Chiu CY, Ward JI. Staphylococcus aureus bacteremia: clinical, serologic, and echocardio- graphic findings in patients with and without endocarditis. Arch Intern Med. 1987;147:457-462. source
- Not checked — no full text of the sourcecites [26] 26. Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, Cheng AC, Dudley T, Oddone EZ. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003;163:2066- 2072. doi: 10.1001/archinte.163.17.2066. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“These characteristics include focal infection with high bacterial density, slow rate of bacterial growth within biofilms, and low microorganism metabolic activity.72”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Therapeutic Principles
What the sources say
- Not checked — no full text of the sourcecites [72] 72. Durack DT, Beeson PB. Experimental bacterial endocarditis, II: survival of a bacteria in endocardial vegetations. Br J Exp Pathol. 1972;53:50-53.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This loss of penicillin-binding proteins during stationary-phase growth may be responsible in part for the inoculum effect observed in vivo and may account for the failure of penicillin in both experimental and human cases of severe streptococcal infections.80”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Inoculum Effect
What the sources say
- Not checked — no full text of the sourcecites [80] 80. Stevens DL, Yan S, Bryant AE. Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis. 1993;167:1401-1405. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“the Duke criteria were originally developed to facilitate epidemiological and clinical research efforts so that investigators could compare and contrast the clinical features and outcomes of various case series of patients.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“However, combination therapy did not reduce mortality or the frequency of cardiac complications.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > IE in Non-IDUs
What the sources say
- Not checked — no full text of the sourcecites [153] 153. Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to paren- teral drugs and in nonaddicts: a prospective study. Ann Intern Med. 1982;97:496-503. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A growing body of evidence suggests that the addition of adjunctive aminoglycoside therapy not only is unnecessary for patients with uncomplicated right-sided native valve S aureus IE but may cause harm.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Right-Sided IE in IDUs
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Linezolid was reported to be effective in the treatment of persistent MRSA bacteremia, 172 but this study had important study design weaknesses.173”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Additional or Adjunctive Therapies
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“However, in an observational study, high-dose daptomycin (≈9 mg/kg per dose) for treatment of left-sided IE was as effective as standard-of-care therapy and cleared MRSA bacteremia significantly faster than did standard-ofcare treatment.155”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Therapy of MSSA IE in Patients Allergic to or Intolerant of β-Lactams
What the sources say
- Not checked — no full text of the sourcecites [155] 155. Carugati M, Bayer AS, Miró JM, Park LP, Guimarães AC, Skoutelis A, Fortes CQ, Durante-Mangoni E, Hannan MM, Nacinovich F, Fernández- Hidalgo N, Grossi P, Tan RS, Holland T, Fowler VG Jr, Corey RG, Chu VH; International Collaboration on Endocarditis. High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Antimicrob Agents Chemother. 2013;57:6213-6222. doi: 10.1128/AAC.01563-13. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Compared with other patients with IE, in general, patients with enterococcal IE are older; are often debilitated; may have complicated, underlying urological conditions, including pre-existing renal failure; may have healthcare-associated infections; and have significant other underlying comorbidities common in older age groups.192”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Role of Aminoglycosides in the Treatment of Patients With Enterococcal IE: Special Considerations
What the sources say
- Not checked — no full text of the sourcecites [192] source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Experimental IE models caused by methicillin-resistant staphylococci demonstrated that vancomycin combined with rifampin and gentamicin is the optimal regimen, and limited clinical reports support this approach.183”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Coagulase-Negative Staphylococci
What the sources say
- Not checked — no full text of the sourcecites [183] 183. Drinković D, Morris AJ, Pottumarthy S, MacCulloch D, West T. Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis. J Antimicrob Chemother. 2003;52:820- 825. doi: 10.1093/jac/dkg440. source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Because of the high mortality rate associated with S aureus PVE, 136 combination antimicrobial therapy is recommended (Table 11).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > S aureus
What the sources say
- Not checked — no full text of the sourcecites [136] 136. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Paré C, Almirante B, Muñoz P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL, Selton-Suty C, Jones SB, Casabé J, Morris A, Corey GR, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of pros- thetic valve endocarditis. JAMA. 2007;297:1354-1361. doi: 10.1001/ jama.297.12.1354. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“Interestingly, all treatment failures with trimethoprim-sulfamethoxazole occurred in patients infected with MSSA in that report, 165 whereas patients with MRSA infection were uniformly cured.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Additional or Adjunctive Therapies
What the sources say
- Not checked — no full text of the sourcecites [165] 165. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim- sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med. 1992;117:390-398. doi: 10.7326/0003-4819-117-5-390. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Increasing the dose of gentamicin in these patients did not result in enhanced efficacy but did increase the risk of nephrotoxicity.194”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Role of Aminoglycosides in the Treatment of Patients With Enterococcal IE: Special Considerations
What the sources say
- Not checked — no full text of the sourcecites [194] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The meta-analysis included small, retrospective studies, however, which limits support for initial combination therapy by some experts.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > IE in Non-IDUs
What the sources say
- Not checked — no full text of the sourcecites [154] 154. McConeghy KW, Bleasdale SC, Rodvold KA. The empirical combina- tion of vancomycin and a β-lactam for staphylococcal bacteremia. Clin Infect Dis. 2013;57:1760-1765. doi: 10.1093/cid/cit560. source
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Levine and Lamp 208 reported daptomycin cure in 6 of 9 patients with E faecium IE; both daptomycin-treated patients with E faecium IE reported by Segreti et al 209 died.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Daptomycin
What the sources say
plainn = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The major advantages of the ampicillin-ceftriaxone regimen are the lower risk of nephrotoxicity and the lack of need for measuring aminoglycoside serum concentrations.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Sixth, in the larger study, there were no significant differences between ampicillin-ceftriaxone and ampicillin-gentamicin in the need for surgery, complications (except for fewer cases of renal failure in the ampicillin-ceftriaxone group), relapse, or mortality.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Not checked — no full text of the sourcecites [191] 191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treat- ing Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261-1268. doi: 10.1093/cid/cit052. 192. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The combination of ampicillin and imipenem acted synergistically in vitro and was effective therapy of multidrug-resistant enterococcal experimental IE.198”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Double-β-Lactam Regimens for E faecalis IE
What the sources say
- Not checked — no full text of the sourcecites [198] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Third, none of the patients in either study developed nephrotoxicity with ampicillin-ceftriaxone therapy, whereas 20 of 87 (23%) ampicillin-gentamicin-treated patients developed nephrotoxicity (P<0.001).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Not checked — no full text of the sourcecites [190] 190. Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574-579. source
- Not checked — no full text of the sourcecites [191] 191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treat- ing Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261-1268. doi: 10.1093/cid/cit052. 192. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Multiple other case reports describe daptomycin failures, some as a result of emergence of daptomycin-resistance during treatment.210,211”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Daptomycin
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“First, these are the largest series of E faecalis IE reported to date, 43 patients in 1 study 190 and 272 in the other study.191”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > October 13, 2015
What the sources say
- Not checked — no full text of the sourcecites [190] 190. Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574-579. source
- Not checked — no full text of the sourcecites [191] 191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treat- ing Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261-1268. doi: 10.1093/cid/cit052. 192. source
plainn = 43- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mave et al 203 compared daptomycin with linezolid for vancomycin-resistant Enterococcus bacteremia.Five patients had E faecium IE; 1 of 2 daptomycin-treated patients and 2 of 3 linezolid-treated patients survived.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Daptomycin
What the sources say
- Not checked — no full text of the sourcecites [203] source
plainn = 5- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Although >90% of enterococci are reportedly susceptible in vitro to daptomycin, the emergence of daptomycin resistance is an increasing problem.207”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Daptomycin
What the sources say
- Not checked — no full text of the sourcecites [207] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Positive blood cultures are a major diagnostic criterion in IE and key to identifying an pathogenic agent and an optimal antimicrobial regimen.225,226”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [225] 225. Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med. 1981;94(pt 1):505-518. source
- Not checked — no full text of the sourcecites [226] 226. Washington JA. The microbiological diagnosis of infective endocarditis. J Antimicrob Chemother. 1987;20(suppl A):29-39. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Escherichia coli and Pseudomonas aeruginosa accounted for 51% of cases, and 59% had PVE.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > HACEK Microorganisms
What the sources say
- Not checked — no full text of the sourcecites [221] 221. Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernández-Hidalgo N, Dickerman S, Bouza E, del Río A, Lejko-Zupanc T, de Oliveira Ramos A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Non-HACEK Gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829-835. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Although management included cardiac surgery in 51% of cases, the in-hospital mortality rate was 24%.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > HACEK Microorganisms
What the sources say
- Not checked — no full text of the sourcecites [221] 221. Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernández-Hidalgo N, Dickerman S, Bouza E, del Río A, Lejko-Zupanc T, de Oliveira Ramos A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Non-HACEK Gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829-835. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The quote only partly states this claim.
In the paper
“Second, serological results were positive in 47.7% of cases, primarily for Coxiella and Bartonella species infection.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [236] 236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. Comprehensive diagnostic strategy for blood culture-negative endocardi- tis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131- 140. doi: 10.1086/653675. source
plainn = 759- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Fungal IE is rare but can develop in a wide range of patients.240,241”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Fungi
What the sources say
- Not checked — no full text of the sourcecites [240] 240. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest. 2002;122:302-310. source
- Not checked — no full text of the sourcecites [241] 241. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endo- carditis: evidence in the world literature, 1965-1995. Clin Infect Dis. 2001;32:50-62. doi: 10.1086/317550. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“First, there was identification of a pathogen in 62.7% of 759 cases; in 2.5%, a noninfectious origin (see below) was confirmed.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [236] 236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. Comprehensive diagnostic strategy for blood culture-negative endocardi- tis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131- 140. doi: 10.1086/653675. source
plainn = 759- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Thus, Aspergillus is a cause of culture-negative IE, and when this occurs, it is usually in a patient with a prosthetic cardiac valve.240”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Fungi
What the sources say
- Not checked — no full text of the sourcecites [240] 240. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest. 2002;122:302-310. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Perhaps the one that has received the most attention is anti-phospholipid antibody (APA) syndrome, 238 which has been described as both a primary and a secondary syndrome and is associated with the presence of APA.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Culture-Negative Endocarditis
What the sources say
- Not checked — no full text of the sourcecites [238] 238. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involve- ment (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93:1579-1587. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Fungal IE has been recognized as a cause of early PVE, but a case series from a single medical center demonstrated that 43% of these cases had symptom onset >1 years after prosthetic valve placement.242”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Fungi
What the sources say
- Not checked — no full text of the sourcecites [242] 242. Nguyen MH, Nguyen ML, Yu VL, McMahon D, Keys TF, Amidi M. Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. Clin Infect Dis. 1996;22:262-267. source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Blood cultures are ultimately positive in most cases caused by the former pathogen, whereas they are rarely positive in cases caused by the latter fungus.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Fungi
What the sources say
- Not checked — no full text of the sourcecites [240] 240. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest. 2002;122:302-310. source
- Not checked — no full text of the sourcecites [241] 241. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endo- carditis: evidence in the world literature, 1965-1995. Clin Infect Dis. 2001;32:50-62. doi: 10.1086/317550. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“A meta-analysis that included 64 reported patients with Candida IE who did not undergo valve surgery because they were deemed to be unacceptable surgical candidates supports the notion that fluconazole suppressive therapy is useful; 20 of 21 patients (95%) who were ultimately treated with long-term suppressive therapy survived during follow-up, which was ≥6 months.244”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Fungi
What the sources say
- Not checked — no full text of the sourcecites [244] 244. Steinbach WJ, Perfect JR, Cabell CH, Fowler VG, Corey GR, Li JS, Zaas AK, Benjamin DK Jr. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005;51:230-247. doi: 10.1016/j. jinf.2004.10.016. source
hedgedconditionaln = 21- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Candida and Aspergillus species account for the large majority of fungal IE, and Candida-related IE is much more common than Aspergillus-related disease.240,241”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Fungi
What the sources say
- Not checked — no full text of the sourcecites [240] 240. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest. 2002;122:302-310. source
- Not checked — no full text of the sourcecites [241] 241. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endo- carditis: evidence in the world literature, 1965-1995. Clin Infect Dis. 2001;32:50-62. doi: 10.1086/317550. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In addition, patients in this trial were young and had limited comorbidity based on a EuroSCORE, a calculated risk of surgical mortality (http://www.euroscore.org), a low prevalence of S aureus IE, and lower mortality compared with most contemporary patient cohorts.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Not checked — no full text of the sourcecites [17] 17. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW. Early surgery versus conven- tional treatment for infective endocarditis. N Engl J Med. 2012;366:2466- 2473. doi: 10.1056/NEJMoa1112843. source
plainn = 76- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Subgroup analysis indicated a lower in-hospital and 1-year mortality with early surgery only in the group of patients with the highest surgical propensity.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Not checked — no full text of the sourcecites [259] 259. Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E, Fowler VG Jr, Gordon D, Grossi P, Hannan M, Hoen B, Muñoz P, Rizk H, Kanj SS, Selton-Suty C, Sexton DJ, Spelman D, Ravasio V, Tripodi MF, Wang A; International Collaboration on Endocarditis-Prospective Cohort Study Investigators. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis [published correction appears in JAMA Intern Med. 2013;173:1846]. JAMA Intern Med. 2013;173:1495-1504. doi: 10.1001/jamainternmed. 2013.8203. source
hedgeddirect- Asserted: fails — The authors may not put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The authors may not put it forward as true. The paper may give no reason why it holds. The quote only partly states this claim.
In the paper
“Only 1 study examined the role of valve surgery in PVE.259 After adjustment for differences in clinical characteristics and survival bias, early valve replacement was not associated with lower mortality compared with medical therapy in the overall cohort.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Not checked — no full text of the sourcecites [259] 259. Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E, Fowler VG Jr, Gordon D, Grossi P, Hannan M, Hoen B, Muñoz P, Rizk H, Kanj SS, Selton-Suty C, Sexton DJ, Spelman D, Ravasio V, Tripodi MF, Wang A; International Collaboration on Endocarditis-Prospective Cohort Study Investigators. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis [published correction appears in JAMA Intern Med. 2013;173:1846]. JAMA Intern Med. 2013;173:1495-1504. doi: 10.1001/jamainternmed. 2013.8203. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After stroke, neurological deterioration can occur as a result of hemorrhagic transformation with anticoagulation during cardiopulmonary bypass or exacerbation of cerebral ischemia attributable to hypotension during cardiac surgery.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Although the authors 17 report a reduction in the composite outcome of in-hospital deaths and embolic events with early surgery (3% versus 23%), the differences between the 2 groups were driven by a significant decrease in embolic events with early surgery.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
What the sources say
- Not checked — no full text of the sourcecites [17] 17. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW. Early surgery versus conven- tional treatment for infective endocarditis. N Engl J Med. 2012;366:2466- 2473. doi: 10.1056/NEJMoa1112843. source
plaindirectn = 76- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In a study 57 based on TEE, mitral vegetations >1 cm in diameter were associated with the greatest frequency of embolism.The association was strengthened when the analysis was limited to those patients who had not yet experienced a clinical embolic event.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [57] 57. Mügge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infec- tive endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol. 1989;14:631-638. doi: 10.1016/0735-1097(89)90104-6. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The first study to evaluate the timing of surgery after stroke in IE that included a risk adjustment for differences in patient characteristics comprised 198 patients.273 Fifty-eight patients who underwent surgery within 1 week of stroke were compared with 140 patients who underwent surgery ≥8 days after stroke.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Not checked — no full text of the sourcecites [273] source
plainn = 198- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Up to 65% of embolic events involve the CNS, and >90% of CNS emboli lodge in the distribution of the middle cerebral artery.277”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [277] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Hospital mortality was numerically but not significantly higher in the early surgery group (22.4% versus 12%).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
What the sources say
- Not checked — no full text of the sourcecites [273] source
plainn = 198- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Rates can be higher if noninvasive imaging, including MRI and CT scanning, is routinely done to detect asymptomatic (silent) emboli.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After hemorrhagic stroke, the risk of exacerbation by surgery is prohibitively high in the first month but can extend beyond 1 month in some patients, possibly because of the presence of undetected mycotic aneurysms (MAs).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Valve Surgery in Patients With Prior Emboli/ Hemorrhage/Stroke
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In addition, a second, albeit infrequent, peak of late embolic events has been observed to occur 15 to 30 weeks after the diagnosis of IE and has been associated with nonhealing vegetations (failure of a vegetation to stabilize or diminish in size) as defined by echocardiography.63”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [63] 63. Konstadt SN, Louie EK, Shore-Lesserson L, Black S, Scanlon P. The effects of loading changes on intraoperative Doppler assessment of mitral regurgitation. J Cardiothorac Vasc Anesth. 1994;8:19-23. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The role of echocardiography in predicting embolic events has been controversial.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In 1 survey 282 that included 4 echocardiographers who were blinded to clinical data, interobserver agreement was mixed on the characterization of vegetations.Agreement was high for the presence of vegetation (98%) and involved site (97%); interobserver agreement was considerably less for vegetation size (73%), mobility (57%), shape (37%), and attachment (40%).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
What the sources say
- Not checked — no full text of the sourcecites [282] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The anatomic vulnerability of this area explains both why abscesses occur in this location and why heart block is a frequent sequela.300”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Not checked — no full text of the sourcecites [300] 300. Arnett EN, Roberts WC. Prosthetic valve endocarditis: clinicopathologic analysis of 22 necropsy patients with comparison observations in 74 nec- ropsy patients with active infective endocarditis involving natural left- sided cardiac valves. Am J Cardiol. 1976;38:281-292. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This criterion is arbitrary and excludes cutaneous embolization, which is common, or embolism occurring before the institution of therapy, which is common among IE patients who develop embolic events.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This time should allow for thrombus organization and prevent the acute hemorrhagic transformation of embolic lesions.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Anticoagulation
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Early surgical intervention may preclude a primary or recurrent major embolic event but exposes the patient to both immediate and lifelong risks of valve replacement if the valve cannot be primarily repaired.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“For example, splenic abscesses generally require splenectomy or a drainage procedure because the usefulness of antimicrobial therapy is in preventing disease extension in the spleen and treating systemic infection rather than eliminating abscesses.314”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Metastatic Foci of Infection
What the sources say
- Not checked — no full text of the sourcecites [314] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Such structural lesions and intracardiac fistulas may be catastrophic; even if their hemodynamic impact is tolerated, these lesions will not heal with medical treatment alone and require urgent operative intervention.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Perivalvular abscesses are particularly common with prosthetic valves because the annulus, rather than the leaflet, is the usual primary site of infection, especially in early PVE and on bioprosthetic valves.302”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Not checked — no full text of the sourcecites [302] 302. Carpenter JL. Perivalvular extension of infection in patients with infec- tious endocarditis. Rev Infect Dis. 1991;13:127-138. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“On ECG, new atrioventricular block has a positive predictive value of 88% for abscess formation but low (45%) sensitivity.298”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Not checked — no full text of the sourcecites [298] 298. Blumberg EA, Karalis DA, Chandrasekaran K, Wahl JM, Vilaro J, Covalesky VA, Mintz GS. Endocarditis-associated paravalvular abscesses: do clinical parameters predict the presence of abscess? Chest. 1995;107:898-903. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Periannular extension is common, occurring in 10% to 40% of all NVE and complicating aortic IE more commonly than mitral or tricuspid IE. [301][302][303][304]”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Not checked — no full text of the sourcecites [301] 301. Fernicola DJ, Roberts WC. Frequency of ring abscess and cuspal infec- tion in active infective endocarditis involving bioprosthetic valves. Am J Cardiol. 1993;72:314-323. source
- Not checked — no full text of the sourcecites [302] 302. Carpenter JL. Perivalvular extension of infection in patients with infec- tious endocarditis. Rev Infect Dis. 1991;13:127-138. source
- Not checked — no full text of the sourcecites [303] 303. Anguera I, Miro JM, Vilacosta I, Almirante B, Anguita M, Muñoz P, Roman JA, de Alarcon A, Ripoll T, Navas E, Gonzalez-Juanatey C, Cabell CH, Sarria C, Garcia-Bolao I, Fariñas MC, Leta R, Rufi G, Miralles F, Pare C, Evangelista A, Fowler VG Jr, Mestres CA, de Lazzari E, Guma JR; Aorto-cavitary Fistula in Endocarditis Working Group. Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J. 2005;26:288-297. doi: 10.1093/eurheartj/ehi034. 304. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Multivariate analysis demonstrated that factors associated with an increased risk of death included moderate to severe heart failure, PVE, and urgent or emergency surgical intervention.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Periannular Extension of Infection
What the sources say
- Not checked — no full text of the sourcecites [304] source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Streptococci and S aureus account for 50% and 10% of cases, respectively, 317,318”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Intracranial MAs
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Outpatient parenteral antibiotic therapy (OPAT) is efficacious, safe, and cost-effective for a variety of infections, [323][324][325] including IE that requires prolonged parenteral therapy in hospitalized patients who otherwise no longer require inpatient care but do require continued parenteral antimicrobial therapy.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Outpatient Therapy
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Neurological signs and symptoms are nonspecific and may suggest a mass lesion or an embolic event.315,317”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Intracranial MAs
What the sources say
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
Outcomes of infective endocarditis have not improved despite medical and surgical advances.
“changes in pathogen prevalence, in particular a more common staphylococcal origin, have affected outcomes, which have not improved despite medical and surgical advances.”
The paper relies on this without support.
The modified Duke criteria are universally accepted.
“These additional parameters have not been formally integrated into the modified Duke criteria, 24 however, which are universally accepted.”
The paper relies on this without support.
Host characteristics such as impaired immunity contribute to challenges in treating IE.
“Host characteristics such as impaired immunity also contribute to challenges in therapeutics.”
The paper relies on this without support.
Antibiotics may fail to eradicate infection as a result of increased binding of the drug to serum proteins, perturbations of antibiotic penetration into the vegetation, and unique antibiotic PK/PD features.
“In addition, antibiotics may fail to eradicate infection as a result of increased binding of the drug to serum proteins, perturbations of antibiotic penetration into the vegetation, and unique antibiotic pharmacokinetic/pharmacodynamic (PK/PD) features.”
The paper relies on this without support.
For enterococci, bactericidal activity can be achieved by the combination of certain β-lactam antibiotics with an aminoglycoside.
“For enterococci, bactericidal activity can be achieved by the combination of certain β-lactam antibiotics (eg, penicillin, ampicillin, and piperacillin) with an aminoglycoside.”
The paper relies on this without support.
The rate of bactericidal activity against some other organisms can be enhanced by a combination of a β-lactam antibiotic plus an aminoglycoside.
“The rate of bactericidal activity against some other organisms can also be enhanced by a combination of a β-lactam antibiotic plus an aminoglycoside.”
The paper relies on this without support.
The addition of gentamicin sulfate to penicillin exerts a synergistic killing effect in vitro on VGS and S gallolyticus (bovis).
“The addition of gentamicin sulfate to penicillin exerts a synergistic killing effect in vitro on VGS and S gallolyticus (bovis).”
The paper relies on this without support.
The combination of penicillin or ceftriaxone with gentamicin results in synergistic killing in animal models of VGS or S gallolyticus (bovis) experimental IE.
“The combination of penicillin or ceftriaxone with gentamicin results in synergistic killing in animal models of VGS or S gallolyticus (bovis) experimental IE.”
The paper relies on this without support.
Both penicillin and ceftriaxone are overall well tolerated but have the potential for causing adverse drug events; common ones include rash, fever, diarrhea, and neutropenia.
“Both penicillin and ceftriaxone are overall well tolerated but, like all antimicrobials, have the potential for causing adverse drug events; some of the more common ones include rash, fever, diarrhea, and neutropenia.”
The paper relies on this without support.
Prolonged intravenous use of vancomycin may be complicated by thrombophlebitis, rash, fever, neutropenia, and rarely ototoxic reactions.
“Prolonged intravenous use of vancomycin may be complicated by thrombophlebitis, rash, fever, neutropenia, and rarely ototoxic reactions.”
The paper relies on this without support.
The likelihood of red man syndrome is reduced with an infusion of vancomycin over at least 1 hour.
“The likelihood of “red man” syndrome is reduced with an infusion of vancomycin over ≥1 hour.”
The paper relies on this without support.
Penicillin resistance in vitro occurs among some strains of VGS and S gallolyticus (bovis).
“Penicillin resistance in vitro occurs among some strains of VGS and S gallolyticus (bovis).”
The paper relies on this without support.
In non-IDUs, S aureus infective endocarditis involves primarily the left side of the heart.
“In non-IDUs, S aureus IE involves primarily the left side of the heart and is associated with mortality rates ranging from 25% to 40%.”
The paper relies on this without support.
In non-IDUs, S aureus infective endocarditis is associated with mortality rates ranging from 25% to 40%.
“In non-IDUs, S aureus IE involves primarily the left side of the heart and is associated with mortality rates ranging from 25% to 40%.”
The paper relies on this without support.
S aureus infective endocarditis in IDUs often involves the tricuspid valve.
“S aureus IE in IDUs often involves the tricuspid valve.”
The paper relies on this without support.
Most CoNS are resistant to methicillin.
“Most CoNS are resistant to methicillin.”
The paper relies on this without support.
S lugdunensis tends to cause a substantially more virulent form of infective endocarditis, with a high rate of perivalvular extension of infection and metastatic infection.
“This species of CoNS tends to cause a substantially more virulent form of IE, with a high rate of perivalvular extension of infection and metastatic infection.”
The paper relies on this without support.
Cefazolin has inadequate blood-brain barrier penetrability.
“In cases of brain abscess complicating MSSA IE, nafcillin is the preferred agent rather than cefazolin, which has inadequate blood-brain barrier penetrability.”
The paper relies on this without support.
Current laboratory screening procedures for detecting penicillin susceptibility may not be reliable.
“Unfortunately, the current laboratory screening procedures for detecting penicillin susceptibility may not be reliable.”
The paper relies on this without support.
Enterococci are the third leading cause of infective endocarditis and account for approximately 10% of cases in non-IDUs.
“Enterococci are the third leading cause of IE and account for ≈10% of cases in non-IDUs.”
The paper relies on this without support.
E faecalis causes approximately 97% of cases of enterococcal infective endocarditis; E faecium causes approximately 1% to 2%; and other species cause approximately 1%.
“E faecalis causes ≈97% of cases of IE; E faecium, ≈1% to 2%; and other species, ≈1%.”
The paper relies on this without support.
Killing of susceptible strains of enterococci requires the synergistic action of penicillin, ampicillin, or vancomycin in combination with either gentamicin or streptomycin.
“Killing of susceptible strains of enterococci requires the synergistic action of penicillin, ampicillin, or vancomycin in combination with either gentamicin or streptomycin.”
The paper relies on this without support.
Enterococci are relatively impermeable to aminoglycosides.
“Enterococci are relatively impermeable to aminoglycosides.”
The paper relies on this without support.
High concentrations of aminoglycosides in the extracellular environment are required to achieve sufficient concentrations of the drug at the ribosomal target within the bacterial cell for bactericidal activity.
“High concentrations of aminoglycosides in the extracellular environment are required to achieve sufficient concentrations of the drug at the site of the ribosomal target within the bacterial cell for bactericidal activity.”
The paper relies on this without support.
If an enterococcal strain is resistant to the cell wall-active agent or high concentrations of an aminoglycoside, then the combination of an aminoglycoside and the cell wall-active agent will not result in bactericidal activity in vitro or in vivo, nor predictably produce a microbiological cure in human enterococcal infective endocarditis.
“If an enterococcal strain is resistant to the cell wall-active agent or high concentrations of an aminoglycoside (500 µg/mL gentamicin or 1000 µg/mL streptomycin), then the combination of an aminoglycoside and the cell wall-active agent will not result in bactericidal activity in vitro or in vivo (ie, in experimental IE models), nor will it predictably produce a microbiological cure in human enter”
The paper relies on this without support.
Since the 2005 AHA statement on antimicrobial therapy of patients with infective endocarditis, the frequency of aminoglycoside-resistant strains of enterococci has increased significantly.
“Since the publication of the latest (2005) AHA statement on antimicrobial therapy of patients with IE, 12 the frequency of aminoglycoside-resistant strains of enterococci has increased significantly.”
The paper relies on this without support.
Approximately 97% of cases of enterococcal infective endocarditis are caused by E faecalis, and the majority of these remain susceptible to beta-lactams and vancomycin, but aminoglycoside resistance is increasing in frequency.
“Approximately 97% of cases of enterococcal IE are caused by E faecalis, and the majority of these remain susceptible to β-lactams and vancomycin, but aminoglycoside resistance is increasing in frequency.”
The paper relies on this without support.
Patients with preexisting mild or severe renal failure may not be able to safely complete a 4- to 6-week course of gentamicin therapy because of gentamicin-associated nephrotoxicity.
“Patients with preexisting mild (creatinine clearance, 30-50 mL/min) or severe (creatinine clearance, <30 mL/min) renal failure may not be able to safely complete a 4-to 6-week course of gentamicin therapy because of gentamicin-associated nephrotoxicity.”
The paper relies on this without support.
Streptomycin is less nephrotoxic than gentamicin.
“The main advantage is that streptomycin is less nephrotoxic than gentamicin.”
The paper relies on this without support.
Streptomycin has a higher risk of ototoxicity than gentamicin, which may not be reversible.
“There are several disadvantages of using streptomycin-containing regimens, including a lack of familiarity among clinicians with streptomycin, a higher risk of ototoxicity, which may not be reversible, and drug availability limitations.”
The paper relies on this without support.
Most strains of E faecalis are inhibited but not killed in vitro by penicillin or ampicillin, with MICs usually 2 to 4 µg/mL penicillin; ampicillin MICs are usually 1 dilution lower.
“Most strains of E faecalis are inhibited but not killed in vitro by penicillin or ampicillin, with MICs usually 2 to 4 µg/ mL penicillin; ampicillin MICs are usually 1 dilution lower.”
The paper relies on this without support.
Cephalosporins and antistaphylococcal penicillins have minimal or no in vitro activity against enterococci.
“Cephalosporins and antistaphylococcal penicillins (oxacillin, nafcillin) have minimal or no in vitro activity against enterococci.”
The paper relies on this without support.
The in vitro activity of carbapenems is variable, with imipenem being most active.
“The in vitro activity of carbapenems is variable, with imipenem being most active.”
The paper relies on this without support.
The likely mechanism of double-β-lactam combinations against enterococci is saturation of different penicillin-binding proteins.
“The likely mechanism of double-β-lactam combinations against enterococci is saturation of different penicillin-binding proteins.”
The paper relies on this without support.
The potential disadvantage of ampicillin-ceftriaxone is the possibility of hypersensitivity reactions to 2 separate β-lactams.
“The potential disadvantage is the possibility of hypersensitivity reactions to 2 separate β-lactams.”
The paper relies on this without support.
Aminoglycoside resistance in enterococci is most commonly the result of acquisition of plasmid-mediated aminoglycoside-modifying enzymes.
“Aminoglycoside resistance in enterococci is most commonly the result of the acquisition of plasmid-mediated aminoglycoside-modifying enzymes.”
The paper relies on this without support.
E faecalis strains resistant to high levels of gentamicin are resistant to most other aminoglycosides, although some are susceptible to streptomycin.
“E faecalis strains resistant to high levels of gentamicin are resistant to most other aminoglycosides, although some of them are susceptible to streptomycin.”
The paper relies on this without support.
The total number of cases published in European studies far exceeds the relatively small number of reported streptomycin-treated patients with enterococcal IE.
“The total number of cases published in the European studies far exceeds the relatively small number of reported streptomycin-treated patients with enterococcal IE.”
The paper relies on this without support.
Combinations of penicillin or ampicillin with gentamicin are preferable to combined vancomycin-gentamicin because of the potential increased risk of ototoxicity and nephrotoxicity with the vancomycin-gentamicin combination.
“Combinations of penicillin or ampicillin with gentamicin are preferable to combined vancomycin-gentamicin because of the potential increased risk of ototoxicity and nephrotoxicity with the vancomycin-gentamicin combination.”
The paper relies on this without support.
Combinations of penicillin or ampicillin and gentamicin are more active than combinations of vancomycin and gentamicin in vitro and in animal models of experimental IE.
“Moreover, combinations of penicillin or ampicillin and gentamicin are more active than combinations of vancomycin and gentamicin in vitro and in animal models of experimental IE.”
The paper relies on this without support.
Rarely, strains of E faecalis produce an inducible β-lactamase.
“Rarely, strains of E faecalis produce an inducible β-lactamase.”
The paper relies on this without support.
β-lactamase-producing E faecalis strains are susceptible to ampicillin-sulbactam and to vancomycin.
“These β-lactamase-producing strains are susceptible to ampicillin-sulbactam and to vancomycin.”
The paper relies on this without support.
Intrinsic penicillin resistance is uncommon in E faecalis but is common in E faecium.
“Intrinsic penicillin resistance is uncommon in E faecalis but is common in E faecium.”
The paper relies on this without support.
Most vancomycin-resistant enterococci are E faecium, and as many as 95% of strains express multidrug resistance to vancomycin, aminoglycosides, and penicillins.
“Most of these strains are E faecium, and as many as 95% of strains express multidrug resistance to vancomycin, aminoglycosides, and penicillins.”
The paper relies on this without support.
Only about 3% of E faecalis strains are multidrug resistant, and many vancomycin-resistant E faecalis are penicillin susceptible.
“Only about 3% of E faecalis strains are multidrug resistant, and many vancomycin-resistant E faecalis are penicillin susceptible.”
The paper relies on this without support.
E faecium IE is uncommon.
“Fortunately, E faecium IE is uncommon.”
The paper relies on this without support.
Linezolid and daptomycin are the only 2 antimicrobial agents currently available in the United States that may be useful for treatment of multidrug-resistant E faecium IE.
“Linezolid and daptomycin are the only 2 antimicrobial agents currently available in the United States that may be useful for the treatment of multidrug-resistant E faecium IE.”
The paper relies on this without support.
Quinupristin-dalfopristin may be active in vitro but only against E faecium and is inactive against E faecalis.
“Quinupristin-dalfopristin may be active in vitro but only against strains of E faecium and is inactive against E faecalis.”
The paper relies on this without support.
Quinupristin-dalfopristin is rarely used because of severe side effects, including intractable muscle pain.
“Quinupristin-dalfopristin is rarely used because of severe side effects, including intractable muscle pain.”
The paper relies on this without support.
Tigecycline is active in vitro against some strains of multidrug-resistant enterococci, but there are minimal published data on its clinical use.
“Tigecycline is active in vitro against some strains of multidrug-resistant enterococci, but there are minimal published data on its use clinically.”
The paper relies on this without support.
Linezolid is bacteriostatic in vitro against enterococci, and susceptibility ranges from 97% to 99%, including multidrug-resistant strains.
“Linezolid is bacteriostatic in vitro against enterococci, and susceptibility of enterococci to linezolid ranges from 97% to 99%, including strains that are multidrug resistant.”
The paper relies on this without support.
Daptomycin has bactericidal activity in vitro against susceptible strains of enterococci.
“Daptomycin is a cyclic lipopeptide antibiotic that has bactericidal activity in vitro against susceptible strains of enterococci.”
The paper relies on this without support.
HACEK microorganisms grow slowly in standard blood culture media, and recovery may require prolonged incubation.
“These microorganisms grow slowly in standard blood culture media, and recovery may require prolonged incubation.”
The paper relies on this without support.
Typically, only a small fraction of blood culture bottles in patients with HACEK IE demonstrate growth.
“Typically, only a small fraction of blood culture bottles in patients with HACEK IE demonstrate growth.”
The paper relies on this without support.
Bacteremia caused by HACEK microorganisms in the absence of an obvious focus of infection is highly suggestive of IE even without typical physical findings.
“Bacteremia caused by HACEK microorganisms in the absence of an obvious focus of infection is highly suggestive of IE even without typical physical findings of IE.”
The paper relies on this without support.
Almost all strains of the HACEK group are susceptible to ceftriaxone (or other third- or fourth-generation cephalosporins).
“Almost all strains of the HACEK group are susceptible to ceftriaxone (or other third-or fourth-generation cephalosporins).”
The paper relies on this without support.
There are only a few case reports of HACEK IE treated with a fluoroquinolone.
“There are only a few case reports of HACEK IE treated with a fluoroquinolone, however.”
The paper relies on this without support.
IE caused by non-HACEK Gram-negative aerobic bacilli is rare.
“IE caused by non-HACEK Gram-negative aerobic bacilli (Enterobacteriaceae and Pseudomonas species) is rare.”
The paper relies on this without support.
Prospective trial data are lacking to define the optimal antimicrobial regimen for IE caused by non-HACEK Gram-negative aerobic bacilli.
“Prospective trial data are lacking to define the optimal antimicrobial regimen for the treatment of IE caused by non-HACEK Gram-negative aerobic bacilli.”
The paper relies on this without support.
Medical therapy may be successful in right-sided P aeruginosa IE in 50% to 75% of cases.
“Medical therapy may be successful in right-sided P aeruginosa IE in 50% to 75% of cases.”
The paper relies on this without support.
Patients with right-sided P aeruginosa IE have typically been IDUs and have high recidivism risk.
“Typically, these patients have been IDUs, and because of their high recidivism risk, avoidance of placement of prosthetic valves is desirable.”
The paper relies on this without support.
Continuous bacteremia and a high frequency of positive blood cultures are typical hallmarks of IE.
“Continuous bacteremia and a high frequency of positive blood cultures are typical hallmarks of this infection.”
The paper relies on this without support.
Failure to culture microorganisms that cause IE can be a major problem that complicates diagnosis and timely, effective treatment.
“Failure to culture microorganisms that cause IE can be a major problem that complicates diagnosis and timely, effective treatment.”
The paper relies on this without support.
The causes of culture-negative IE may include inadequate microbiological techniques, infection with highly fastidious bacteria or fungi, noncultivatable agents, or previous administration of antimicrobial agents before blood cultures.
“This may be attributable to inadequate microbiological techniques, infection with highly fastidious bacteria or fungi, noncultivatable agents, or the previous administration of antimicrobial agents before blood cultures were obtained.”
The paper relies on this without support.
IE patients with blood cultures initially negative after only a few days of antibiotic therapy may have positive blood cultures after several days without antibiotics.
“IE patients with blood cultures that are initially negative after only a few days of antibiotic therapy may have positive blood cultures after several days without antibiotics.”
The paper relies on this without support.
The blood cultures of patients who receive longer courses of high-dose bactericidal antimicrobials may remain negative for weeks.
“The blood cultures of patients who receive longer courses of high-dose bactericidal antimicrobials may remain negative for weeks.”
The paper relies on this without support.
Certain therapeutic agents, including aminoglycosides, have potentially toxic effects that dictate limitation or avoidance of use if at all possible.
“On the other hand, certain therapeutic agents, including aminoglycosides, have potentially toxic effects that dictate limitation or avoidance of use if at all possible.”
The paper relies on this without support.
During the period between collection of blood cultures and determination of a pathogen, patients are often treated empirically for the more common bacterial causes of IE, which can result in exposure to potentially toxic therapy that could be avoided with earlier pathogen identification.
“During this period, patients are often treated empirically for the more common bacterial causes of IE, which can result in exposure to potentially toxic therapy that could be avoided with earlier pathogen identification.”
The paper relies on this without support.
During the period between collection of blood cultures and determination of a pathogen or if blood cultures are ultimately deemed culture negative, empirical therapy is generally required.
“During the period between the collection of blood cultures and the determination of a pathogen or if blood cultures are ultimately deemed culture negative, empirical therapy is generally required.”
The paper relies on this without support.
Collection of additional clinical and laboratory data often dictates subsequent revisions in initial empirical therapy.
“Collection of additional clinical and laboratory data often dictates subsequent revisions in initial empirical therapy that will be administered over the treatment course.”
The paper relies on this without support.
The organisms that have garnered the most attention as causes of culture-negative IE are Bartonella species, Chlamydia species, C burnetii, Brucella species, Legionella species, Tropheryma whipplei, Candida, and non-Candida fungi.
“The organisms that have garnered the most attention are Bartonella species, Chlamydia species, C burnetii, Brucella species, Legionella species, Tropheryma whipplei, Candida, and non-Candida fungi (particularly Aspergillus species).”
The paper relies on this without support.
The last 2 groups of organisms (Candida and non-Candida fungi) are especially relevant to PV recipients.
“The last 2 groups of organisms are especially relevant to PV recipients.”
The paper relies on this without support.
With special diagnostic techniques, Bartonella species, C burnetii, and Brucella species have been identified in the majority of cases of culture-negative IE caused by fastidious organisms.
“With the use of special diagnostic techniques, Bartonella species, C burnetii, and Brucella species have been identified in the majority of cases of culture-negative IE caused by fastidious organisms.”
The paper relies on this without support.
In some cases, serological and special blood culture techniques can be helpful for culture-negative IE.
“In some cases, serological and special blood culture techniques can be helpful.”
The paper relies on this without support.
In other cases, tissue (usually valve) screening is required for culture-negative IE.
“In other cases, tissue (usually valve) screening is required.”
The paper relies on this without support.
Diagnostic methods for resected valve tissue include microbiological, histopathological, and molecular techniques, the last of which includes gene amplification with PCR.
“Diagnostic methods for resected valve tissue include microbiological, histopathological, and molecular techniques, the last of which includes gene amplification with PCR methods.”
The paper relies on this without support.
Most clinical laboratories do not perform molecular screening, and specimens must be sent to reference laboratories.
“Unfortunately, most clinical laboratories do not perform molecular screening, and specimens must be sent to reference laboratories.”
The paper relies on this without support.
Incidence data from population-based surveys for IE caused by these organisms are lacking in the United States.
“Incidence data from population-based surveys for IE caused by these organisms are lacking in the United States.”
The paper relies on this without support.
Treatment of culture-negative IE without prior antibiotic exposure is based on limited data.
“Treatment of the wide variety of microorganisms that cause culture-negative IE without prior antibiotic exposure has been described anecdotally, and regimens of choice are based on limited data and can be found in other publications.”
The paper relies on this without support.
Noninfectious causes of valvular vegetations can produce a syndrome similar to culture-negative IE.
“Noninfectious causes of valvular vegetations can produce a syndrome similar to culture-negative IE.”
The paper relies on this without support.
Sterile valvular vegetations form and embolize, clinically mimicking culture-negative IE.
“Sterile valvular vegetations form and embolize, clinically mimicking in many respects culture-negative IE.”
The paper relies on this without support.
The mitral valve is most often affected, and valvular regurgitation is the predominant functional abnormality in APA syndrome with valvular involvement.
“The mitral valve is most often affected, and valvular regurgitation is the predominant functional abnormality seen in APA syndrome with complicating valvular involvement.”
The paper relies on this without support.
Numerous other causes of noninfective vegetative endocarditis can mimic IE.
“Numerous other causes of noninfective vegetative endocarditis can mimic IE.”
The paper relies on this without support.
The survival rate for patients with mold-related infective endocarditis is less than 20%.
“The survival rate for patients with mold-related IE is <20%.”
The paper relies on this without support.
Stroke is an independent risk factor for postoperative mortality in infective endocarditis patients.
“Stroke is an independent risk factor for postoperative mortality in IE patients.”
The paper relies on this without support.
The novel oral anticoagulants are not approved for use with either mechanical valves or bioprosthetic valves when risk factors for thromboembolism exist.
“The novel oral anticoagulants are not approved for use with either mechanical valves or bioprosthetic valves when risk factors for thromboembolism exist (eg, atrial fibrillation).”
The paper relies on this without support.
Clinical parameters for the diagnosis of perivalvular extension of IE are inadequate.
“Clinical parameters for the diagnosis of perivalvular extension of IE are inadequate.”
The paper relies on this without support.
TEE can demonstrate the distinctive flow patterns of fistulas and pseudoaneurysms and can rule out communications from unruptured abscess cavities.
“When combined with spectral and color Doppler techniques, TEE can demonstrate the distinctive flow patterns of fistulas and pseudoaneurysms and can rule out communications from unruptured abscess cavities.”
The paper relies on this without support.
The most frequent complications of IE are heart failure and systemic emboli.
“Patients selected for OPAT should be at low risk for the complications of IE, the most frequent of which are heart failure and systemic emboli.”
The paper relies on this without support.
The period of greatest risk for systemic emboli is before or within the first 1 to 2 weeks of antimicrobial therapy.
“The period of greatest risk for systemic emboli is before or within the first 1 to 2 weeks of antimicrobial therapy, although serious complications such as heart failure and rupture of MAs may develop weeks to months after the initiation of antimicrobial therapy.”
The paper relies on this without support.
Serious complications such as heart failure and rupture of MAs may develop weeks to months after the initiation of antimicrobial therapy.
“although serious complications such as heart failure and rupture of MAs may develop weeks to months after the initiation of antimicrobial therapy.”
The paper relies on this without support.
The risk for drug-related side effects usually increases with a prolonged drug exposure.
“The risk for drug-related side effects usually increases with a prolonged drug exposure (eg, vestibular, auditory, and nephrotoxicity resulting from aminoglycosides; leukopenia caused by β-lactams and vancomycin; and nephrotoxicity resulting from the combination of vancomycin and gentamicin) and requires close monitoring by the home infusion team consisting of representatives from nursing and pha”
The paper relies on this without support.
The majority of patients with IE are cured with appropriate medical and, if necessary, surgical treatment.
“The majority of patients with IE are cured with appropriate medical and, if necessary, surgical treatment.”
The paper relies on this without support.
Routine blood cultures after completion of antimicrobial therapy have a low likelihood of positive result in a patient who is otherwise without evidence of active infection.
“Routine blood cultures are no longer recommended after the completion of antimicrobial therapy because the likelihood of a positive culture result in a patient who is otherwise without evidence of active infection is low.”
The paper relies on this without support.
Developing or worsening heart failure is a complication that should be considered during short-term follow-up.
“Developing or worsening heart failure is a second complication that should be considered during short-term followup.”
The paper relies on this without support.
Valve function can deteriorate as a result of ongoing infection or mechanical stress unrelated to infection.
“Although new onset of heart failure caused by valvular dysfunction is unlikely during this period, valve function can deteriorate as a result of ongoing infection or mechanical stress unrelated to infection.”
The paper relies on this without support.
Antibiotic toxicity still can occur after the completion of treatment.
“Antibiotic toxicity still can occur after the completion of treatment and is the third complication that should be considered during short-term follow-up.”
The paper relies on this without support.
Delayed ototoxicity can occur because of previous use of aminoglycosides.
“The first is delayed ototoxicity because of the previous use of aminoglycosides.”
The paper relies on this without support.
No tools are routinely available for monitoring vestibular function.
“No tools are routinely available for monitoring vestibular function, and patients should be told to report the onset of any symptoms of vestibular toxicity during or after treatment.”
The paper relies on this without support.
Clostridium difficile infection is an antibiotic-related adverse event.
“The second antibiotic-related adverse event is Clostridium difficile infection.”
The paper relies on this without support.
Onset of C. difficile diarrhea can be delayed as long as 4 weeks after the last dose of antibiotic.
“Onset of diarrhea can be delayed as long as 4 weeks after the last dose of antibiotic.”
The paper relies on this without support.
IE can mimic a variety of febrile illnesses.
“This is necessary because IE can mimic a variety of febrile illnesses.”
The paper relies on this without support.
Antibiotics prescribed for nonspecific or unproved febrile syndromes are a major cause of culture-negative IE.
“Antibiotics prescribed for nonspecific or unproved febrile syndromes are a major cause of (blood) culture-negative IE, and this practice should be strongly discouraged.”
The paper relies on this without support.
Dental disease is almost entirely preventable if patients are compliant with 4 measures.
“Dental disease is almost entirely preventable if patients are compliant with 4 measures.”
The paper relies on this without support.
The cause of both periodontal disease and caries is bacterial plaque accumulation on teeth, and prevention is dependent on keeping teeth free of plaque.
“First, the cause of both periodontal disease and caries is bacterial plaque accumulation on teeth, and prevention is dependent on keeping teeth free of plaque.”
The paper relies on this without support.
The degree to which sugar and other refined carbohydrates are eliminated from the diet will have a major impact on the growth of pathogenic bacterial species, some of which are responsible for IE.
“The degree to which sugar and other refined carbohydrates are eliminated from the diet will have a major impact on the growth of pathogenic bacterial species, some of which are responsible for IE.”
The paper relies on this without support.
Daily use of a high-concentration fluoridated toothpaste will help to ensure that acid from plaque does not decalcify tooth structures and result in caries.
“Finally, the daily use of a high-concentration fluoridated toothpaste will help to ensure that the acid from plaque does not decalcify tooth structures and result in caries.”
The paper relies on this without support.
Fluoroquinolones are highly active in vitro against HACEK microorganisms.
“Fluoroquinolones are highly active in vitro against HACEK microorganisms.”
The paper relies on this without support.
Published data on the use of fluoroquinolones for endocarditis caused by HACEK are minimal.
“Published data on the use of fluoroquinolones for endocarditis caused by HACEK are minimal.”
The paper relies on this without support.
Intramuscular injection of ceftriaxone is painful.
“Patientsshould be informed that intramuscular injection of ceftriaxone is painful.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Risk of Embolization
“The benefits of early surgery were demonstrated in the prospective, randomized trial 12 that was discussed earlier in this document.”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Surgical Management
“only 1 small, randomized trial 17 has been performed to date to examine the role of valve surgery in the management of IE.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Relatively Penicillin-Resistant VGS and S gallolyticus (bovis) (MIC >0.12-<0.5 µg/mL)
“Vancomycin alone may be a reasonable alternative if the patient is intolerant of β-lactam therapy (Class IIb; Level of Evidence C).”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > Recommendations 1. It is reasonable to administer penicillin for 4 weeks with single daily-dose gentamicin for the first 2 weeks of therapy (Class IIa; Level of Evidence B). 2. If the isolate is ceftriaxone susceptible, then ceftriaxone alone may be considered (Class IIb; Level of Evidence C). 3. Vancomycin alone may be a reasonable alternative in patients who are intolerant of β-lactam therapy (Class IIa; Level of Evidence C).
“Vancomycin alone may be a reasonable alternative in patients who are intolerant of β-lactam therapy (Class IIa; Level of Evidence C).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > IE in Non-IDUs
“daptomycin may be a reasonable alternative to daptomycin for left-sided NVE caused by MRSA”
§ Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America > IE in Non-IDUs
“Daptomycin may be a reasonable alternative to vancomycin for treatment of left-sided IE resulting from MRSA”
Citations
Cites
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Self-citationLiu, C., Bayer, A. S., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,260
Self-citationProposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027
Self-citationCraig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Murdoch, D. R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.603 · Cited by 2,362
Osmon, D. R., Berbari, E. F., Berendt, A. R., Lew, D., Zimmerli, W., Steckelberg, J. M., Rao, N., Hanssen, A. D., & Wilson, W. R. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis803 · Cited by 2,289
Self-citationGuidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Self-citation
Research works printed but not linked: 3
- Kanavos K Antoniadou A Venetis C Gezerlis P Giamarellou H. Retrospective analysis of Duke’s criteria in 60 cases of infective endocarditis in Greece [abstract 138]. Paper presented at: Third International Symposium on Modern Concepts in Endocarditis; July 13–15 1995; Boston MA.
- 10.1016/S0025-6196(11)63302-8 · DOI
- 10.1016/S0025-6196(11)64307-3 · DOI
Cited by
Sorted by citations
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“Although it is well known that endocarditis requires prolonged antimicrobial therapy, severe disease more typically presents as cardiac failure/cardiogenic shock and emboli rather than as sepsis or septic shock [206, 207].”
BackgroundSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
Turner, N., Sharma‐Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., Holland, T. L., & Fowler, V. G. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0147-4 · Cited by 2,173
Self-citationIsselbacher, E. M., Preventza, O., Hamilton Black, J., Augoustides, J. G., Beck, A. W., Bolen, M. A., Braverman, A. C., Bray, B. E., Brown-Zimmerman, M. M., Chen, E. P., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001106 · Cited by 2,082
2023 ESC Guidelines for the management of endocarditis
Delgado, V., Marsan, N. A., de Waha, S., Bonaros, N. E., Brida, M., Burri, H., Caselli, S., Doenst, T., Éderhy, S., Erba, P. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad193 · Cited by 2,039
Self-citation
Metadata
- Authors
- Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., Bolger, A. F., Steckelberg, J. M., Baltimore, R. S., Fink, A. M., O’Gara, P., Taubert, K. A., & on behalf of the American Heart Association Committee on Rheumatic Fever, E.
- Affiliations
- American Heart Association (US)
- ORCID
- Venue
- Circulation
- Published
- 2015-10-13
- Volume
- 132
- Issue
- 15
- Pages
- 1435-1486
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1905008412
- Cited by
- 3,232
- References
- 338
- Citations by year
- 2026: 265 · 2025: 337 · 2024: 350 · 2023: 337 · 2022: 348 · 2021: 344 · 2020: 346 · 2019: 301 · 2018: 258 · 2017: 207 · 2016: 120 · 2015: 12
- FWCI
- 156.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Touro Scholar (Touro College) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Keywords
- infective endocarditis, adults, diagnosis, antimicrobial therapy, complication management, Staphylococcus aureus, nosocomial infections, treatment guidelines
- MeSH terms
- Adult, Anti-Infective Agents, Anticoagulants, Candidiasis, Diagnostic Techniques, Cardiovascular, Endocarditis, Heart Valve Prosthesis, Humans, Rheumatic Heart Disease, Risk Factors, Staphylococcal Infections, Streptococcal Infections, Prosthesis-Related Infections, Bacteremia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review